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Abstract 
 
Intravascular stents of various designs are currently used to prop open 
diseased arteries and there is evidence that different stent geometries 
have different in-stent restenosis rates. The majority of commercially 
available stents are designed generically to fit all individuals. Recent 
advances in imaging and catheter technologies, however, allow 
measurement of lesion shape and stiffness. Incorporating patient specific 
data into the stent design process could enable the development of 
customised stents. Considering the variety of lesion types, it is envisaged 
that better outcomes will be achieved if a stent is custom designed in 
such a way that it has variable radial stiffness longitudinally to hold the 
varying pressure of plaque and healthy artery at the same time while 
maintaining an acceptable lumen diameter. This type of operation is 
suitable for topology optimisation potentially allowing for optimal material 
distribution of a stent. The primary aim of this research is to develop new 
stent designs for a set of plaque types and investigate the final radius of 
the lumen after stent implantation. Stent geometries were obtained by 
topology optimisation for minimised compliance under different stenosis 
levels and plaque materials.  Three types of stenosis levels by area, i.e. 
30%, 40% and 50% with each type having three different plaque material 
properties i.e. calcified, cellular and hypocellular were studied. The 
optimisation results were transformed to clear design concepts and their 
performance was evaluated by implanting them in their respective 
iii 
 
stenosed artery types using finite element analysis. The results were 
compared with a generic stent in similar arteries, which showed that the 
new designs showed less recoil. In the hardest (calcified) of plaques 
studied, topology optimised designs overall resulted in 2%, 2% and 6% 
residual area stenosis compared to 10%, 29% and 35% from the generic 
design in arteries with 30%, 40% and 50% stenosis respectively. It was 
shown that higher material distribution resulted in the central region of 
the stent in order to resist implantation recoil due to higher plaque 
compressive loads. Additive manufacturing (AM) was utilised to validate 
the computational approach used in this thesis. This work provides a 
proof of concept for stents tailored to specific lesions in order to minimise 
recoil and maintain a patent lumen in stenotic arteries. 
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Figure 7-12: Mesh 3 (47507 elements) with torsional loading and MMS 0.5: (a) 
element density distribution, ρ, representing material densities between 0-1 (b) 
threshold 0.25 for element filtering and (c) FEM smoothing of the filtered elements.
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1.  Introduction 
 
 
1.1 Background 
Cardiovascular disease (CVD) is the main cause of death in England. 
Each year in England and Wales more than 124,000 deaths are caused 
by CVD among which nearly half are due to Atherosclerosis [1]. 
Atherosclerosis is the most common type of heart disease, in which 
plaque is accumulated in coronary arteries restricting oxygen-rich blood 
supply to a region of heart muscle. This could result in the death of that 
region and ultimately myocardial infarction (heart attack). 
Treatment of blocked arteries can include invasive surgeries such as 
coronary artery bypass surgery, balloon angioplasty or stent placement. 
Coronary artery bypass surgery or grafting (CABG) involves the creation 
of an alternative passage for blood to bypass the obstruction and was 
performed first in 1960. This procedure is highly invasive for the patient 
as it requires the opening of the chest to allow access to the heart. In 
1977, a less invasive technique was introduced by Dr. Gruentzig called 
angioplasty [4]. During this minimally invasive surgery (MIS), a balloon 
catheter is mounted over a guide wire and is advanced to the narrowed 
section of the vessel through a small skin puncture in the groin or wrist 
area. Subsequently, the balloon is inflated at high pressure which 
compresses the plaque against the arterial wall and results in larger 
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lumen (internal space of an artery) diameter restoring the blood flow 
through that region.  
After deflating the balloon catheter, some of the lumen gain is lost by 
elastic recoil of the vessel wall. This lumen loss could be limited by 
placement of a tubular mesh shaped mechanical scaffold called a stent, 
which in most cases provides a permanent support to the diseased 
vessel. The first human implantation of a stent was carried out in 1986 
[2]. Since then, technological advancements in stent design, materials, 
deliverability and drug coatings have expanded the application and 
success rate of the procedure. Presently, the main concern about this 
treatment is restenosis, or the re-blocking of the stented artery, normally 
known as in-stent restenosis (ISR). 
As the stent is a foreign material to the affected artery, its presence and 
mechanical stress on the artery lead to a large number of failures due to 
restenosis. Restenosis typically occurs through a process of neointimal 
hyperplasia (NH), involving thrombus formation, inflammation and 
smooth muscle cell proliferation [5]. In the early days of the stenting 
procedure, approximately one third of patients suffered from in-stent 
restenosis within 6 months of stent implantation. Subsequently, there has 
been a tremendous effort devoted to minimising the failures due to 
restenosis [3].  
With the advent of drug-eluting stent (DES) technology, success has 
been achieved in reducing restenosis rates. These stents are covered 
with biodegradable polymer coatings consisting of anti-proliferative drugs 
designed to minimise smooth muscle cell proliferation. Although drug-
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eluting stents have decreased restenosis rates in coronary arteries to 
near 10%, incomplete endothelialisation of stent struts and lack of 
extensive long-term follow up still limit this technology.  
It has been shown that stent design influences treatment outcome and is 
a major risk factor for restenosis in bare metal stents (BMS). Advances 
in stent design have reduced the restenosis rates to around 20% in some 
stents and over 40% in others, with variation depending upon the stent 
design [3]. Such significant variations show that optimisation of the 
mechanical and geometrical design parameters could further reduce the 
incidences of restenosis. 
1.2 Research Motivation 
Since their first use in 1986 [2], stents have evolved in terms of design, 
materials and drug coatings to achieve better post-implantation results. 
Every year, more than 3 million stents are implanted worldwide and 
around 600,000 implanted in the UK of which nearly 50,000 are coronary 
stents [3,4]. Presently, the main concern about this treatment is 
restenosis, or the re-blocking of the stented artery, normally known as in-
stent restenosis (ISR). Nowadays, a variety of stent designs is available, 
differing with regard to material, strut thickness, coating and drug elution. 
These stent varieties trigger different vascular behaviours. Stenting is not 
risk free and stent design alone is an independent predictor of re-blocking 
conditions such as thrombosis and neointimal hyperplasia [5]. These 
adverse conditions mainly depend upon how the stent geometry interacts 
with the arterial surface.  
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Currently stenting (stent deployment) of diseased arteries generally 
involves the use of only a set of “off-the-shelf” devices. Especially treating 
diseased arteries with complex geometry and different stiffnesses of 
plaques can result in unacceptably low lumen area and shape.  
Computational modelling coupled with additive manufacturing (AM) 
offers a cost effective way to design, pre-clinically test and evaluate the 
performance and effectiveness of stents. Existing studies dealing with 
numerical modelling of stent-artery interactions have very rarely focused 
lesion-specific stent with no optimisation studies in this area. Therefore, 
there is a significant need to analyse and develop lesion-specific stent 
designs that suits best the challenging vessel geometry and maintain 
vessel lumen area. 
1.3 Thesis Outline 
A brief description of the thesis chapters is given below: 
Chapter 2 discusses in detail the relevant literature that underpins this 
thesis. Starting from the physiology of coronary arteries, the pathology of 
atherosclerosis and its treatment procedures. It explains stent types and 
the post-implantation complications. A detailed overview is presented 
about the finite element analysis (FEA) modelling of stents and structural 
optimisation methods. This chapter also introduces additive 
manufacturing, which is utilised produce one of the new stent designs to 
test and validate the computational approach taken in this thesis. 
Chapter 3 presents the research novelty of this work by pointing out gaps 
in the literature along with aims and objectives of the current study. 
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Chapter 4 describes the methodology followed for the optimisation of 
lesion-specific stents. It describes the contact analyses between a force 
evaluating cylinder, a generic stent and different types of plaques. It 
explains in detail about the geometry creation for the analysis models, 
material selection, loading and boundary conditions and other analysis 
parameters. The chapter later details the topology optimisation technique 
used and the steps taken to develop a new stent design concepts using 
this method along with initial exploration to demonstrate topology change 
with loading. It then explains the model setup and the different plaque 
types used to design lesion-specific stents. 
Chapter 5 describes the experimental work done to validate the 
computational approach used in the thesis. It presents the work carried 
out to create a test-rig for mock arteries made of silicone tubes and the 
implantation of scaled models of polymer stents made with additive 
manufacturing. 
Chapter 6 presents the results of all the analyses and optimisation 
methods used to develop and optimise lesion-specific stent designs 
along with the findings of proof-of-concept experiments. It also discusses 
the results achieved in the current work, their benefit and potential 
solutions for application. 
Chapter 7 presents the conclusions of the current work, its limitations 
and recommendations for future research. 
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2.  Literature Review 
 
2.1 Introduction 
This chapter covers the literature that underpins this thesis. As stated in 
the earlier chapter, the aim of this study is to investigate and develop 
lesion-specific stents. Before addressing this issue, it is necessary to 
provide an introduction to coronary heart disease and its treatment types. 
A detailed account of the impact of stent design on arterial wall 
mechanics is presented. This is followed by a review of stent design FEA 
and structural optimisation methods. Finally, a summary of the key 
decisions made to formulate the research methodology is given. The 
structure of the literature review is shown in Figure 2-1. 
 
Figure 2-1: Structure of literature review. 
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2.2 Physiology of Coronary Arteries 
The heart muscle is a muscular pump which moves blood around the 
body. The heart also needs its own blood supply to work properly, and 
this is done by vessels called coronary arteries. There are two main 
coronary arteries, the left coronary artery (LCA) and the right coronary 
artery (RCA), both originating from the base of aorta. The segment of the 
LCA between the aorta and the first bifurcation is known as the left main 
artery (LM). The left main bifurcates into the left anterior descending 
artery (LAD) and the left circumex artery (LCX). An overview of these 
coronary arteries is illustrated in Figure 2-2. 
 
Figure 2-2: Schematic overview of the main coronary arteries (RCA = right coronary artery, LCA = left 
coronary artery, LM = left main artery, LCX = left circumex artery, LAD = left anterior descending 
artery) [6]. 
Healthy arteries consist of three different layers, the tunica intima, the 
tunica media and the tunica adventitia as shown in Figure 2-3. The tunica 
intima is the thin layer closest to the lumen, which consists of a single 
layer of endothelial cells on a layer of connective tissue. The tunica media 
is made up of smooth muscle cells surrounded by a matrix of elastin and 
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collagen fibres, giving strength to the intimal layer. The tunica adventitia, 
which is the outermost layer, forms a protective layer around the artery. 
 
Figure 2-3: Structure and composition of the arterial wall [7]. 
2.3 Pathology of Atherosclerosis  
Atherosclerosis is a disease in which plaque is accumulated in arteries 
restricting blood supply to a region of heart muscle and could lead to a 
heart attack. The molecular mechanism involved in atherosclerosis is not 
yet completely understood. However, it is known that injury of the 
endothelial layer and inflammatory processes play an important role [8]. 
The formation of plaque (Figure 2-4) starts with the dysfunction of the 
endothelial wall [9]. More precisely, the permeability of the endothelial 
layer changes for the active proteins, such as low density lipoprotein 
(LDL). LDL acts as a transport medium of cholesterol and it is necessary 
for the metabolism of the muscle cells in the tunica media.  
Things go wrong when the permeability of the endothelial layer increases 
and causes LDL accumulation between the tunica intima and tunica 
media. The condition is worsened when part of this LDL oxidises, and the 
presence of oxidised LDL is directly related to plaque [10]. This situation 
triggers further complex processes involving smooth muscle cell 
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migration and vessel growth. In an advanced stage, a considerable 
reduction in the artery lumen is seen which is known as stenosis. 
 
Figure 2-4: Progression of atherosclerosis in coronary arteries: from normal artery (left panel) to 
severe atherosclerosis (rightmost panel) [11]. 
A significant narrowing of an artery due to atherosclerosis may induce 
oxygen deficiency in the downstream regions of the heart and can 
ultimately lead to heart attack or even death. Major risk factors of 
atherosclerosis (Figure 2-5) include smoking, obesity, high blood 
cholesterol, high blood pressure and diabetes [12]. 
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Figure 2-5: Main causes of Atherosclerosis [12]. 
2.4 Treatment 
Treatment of severe stenosis includes bypass surgery, balloon 
angioplasty and stent placement. With bypass surgery the flow through 
the blocked artery is given a new pathway through a relocated vessel of 
the patient placed across the stenosis. This procedure is highly invasive 
as it requires the opening of the chest to allow access to the heart. In 
order to reduce the hospital stay, and the risks and costs associated with 
this high invasive surgery, stenosis can also be treated with less invasive 
techniques such as angioplasty procedures (with or without stent).  
Angioplasty is a much less invasive technique which involves opening 
the stenosed artery by balloon inflation [13]. This minimally invasive 
procedure consists of a balloon catheter insertion into the diseased 
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vessel from a small incision in the femoral or radial artery. The collapsed 
balloon catheter is positioned in the narrowed segment of the target 
vessel. Subsequently, the balloon is inflated and when the physician is 
satisfied with the achieved luminal gain, the balloon is deflated and the 
catheter removed. 
Due to the less invasive nature, the patient recovers faster compared to 
bypass surgery. However, there are still problems limiting the success of 
angioplasty. In the short term, elastic recoil from the vessel is seen as 
soon as the balloon is removed due to the energy released by the elastic 
fibres in the vessel wall after balloon deflation. In the long term, 
restenosis of the vessel wall is responsible for re-narrowing of the lumen. 
These problems lead to the development of a second revolutionary 
treatment, the coronary stent, which was first implanted by Sigwart et al. 
in 1986 [2]. This bare metal, self-expanding stent, known as the “Wall” 
stent was able to provide a scaffold to the diseased artery and prevented 
elastic recoil. 
2.5 Cardiovascular Stents and its Complications 
Cardiovascular stents are tube-like expandable devices used to open 
narrowed (diseased) arterial segments to restore the blood flow to the 
heart muscle. The implantation of stents is currently an important part of 
most interventional procedures for heart treatment. Most commonly, 
stents are taken to the diseased artery mounted on a delivery system, 
made of a balloon catheter and guide wire, via a femoral artery in the 
groin or radial artery in the wrist. Figure 2-6 illustrates the stent treatment 
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compared to angioplasty procedure for a blocked coronary artery caused 
by atherosclerosis. 
 
Figure 2-6 : Diagram showing (a) angioplasty procedure and (b) stenting procedure. [12]. 
A number of different stent types and designs have emerged due to the 
growing use of stents. Table 2-1 illustrates some of the available stents 
with their manufacturers and characteristics. Stents can be classified into 
different categories depending upon their mechanism of expansion i.e. 
self-expanding or balloon expandable, their material or coating. Although 
there are many applications for stents (oesophageal, tracheabroncal, 
biliary, renal etc.), this report mainly focuses on a cardiovascular 
environment but its findings can be applied to other intravascular 
applications. 
  
 
 
13 
 
Table 2-1: Selected stent characteristics and their manufacturers [14]. 
 
Compared to balloon angioplasty treatment, the ratio of restenosis after 
deployment of a stent reduces to 15-20% from 33%-50% [15]. 
Unfortunately, the major drawback of this stenting procedure is in-stent 
restenosis, i.e., the reoccurrence of stenosis. This phenomenon is related 
to both arterial injury and an inflammatory response of the vessel wall 
against the stent struts (Figure 2-7). The arterial response mainly results 
in stent thrombosis (ST) and neointimal hyperplasia (NH), which is the 
abnormal growth of endothelial cells [16]. 
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Figure 2-7: In-stent restenosis. Open source image [17]. 
Zahedmanesh et al. have described in detail the mechanism of in-stent 
restenosis upon stent implantation [18]. The process starts with 
disruption of the inner endothelial wall of an artery by stent struts followed 
by cell growth around the struts.  
Table 2-2 summarises some of the risk factors involved in stent 
thrombosis. 
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Table 2-2: Risk factors of Stent Thrombosis [19]. 
In the case of BMS, restenosis occurs in more than 20% of the treated  
artery sections [20–22]. Figure 2-8 illustrates some of the restenosis risk 
Selected Multifactorial Causes of ST 
Stent factors 
Hypersensitivity to drug coating or polymer 
Incomplete endothelialisation 
Stent design 
Covered stents  
Patient factors 
PCI for acute coronary syndrome/ST-
segment 
elevation MI 
Diabetes mellitus 
Renal failure 
Impaired left ventricular function 
Premature cessation of dual antiplatelet 
therapy 
Aspirin non-responsiveness 
Clopidogrel non-responsiveness 
Glycoprotein IIb/IIIa inhibitors 
Prior brachytherapy 
Malignancy 
Saphenous vein graft disease 
Lesion characteristics 
Lesion/stent length 
Vessel/stent diameter 
Complex lesions (bifurcation lesions, 
chronic total occlusions) 
Saphenous vein graft target lesion 
Stasis 
Procedural factors 
Inadequate stent expansion/sizing 
Incomplete stent apposition 
Stent deployment in necrotic core 
Residual edge dissection 
MI =myocardial infarction; PCI = percutaneous coronary intervention; ST =stent 
thrombosis. 
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factors influenced by stent attributes. This problem of re-narrowing has 
been significantly reduced to approximately 10% [20,23] by the 
introduction of DES. But soon after its introduction the results were 
shadowed by concerns regarding thrombogenicity and long-term 
outcomes [24]. Therefore, efforts aiming at reducing the arterial injury 
caused by stent implantations remain crucial. 
 
Figure 2-8: Some of the factors affecting in-stent restenosis. 
From the literature previously discussed and clinical evidence, it was 
found that two methods are commonly adopted to reduce in-stent 
restenosis: stent design alteration and by changing stent materials and 
coatings to inhibit the abnormal growth of arterial inner wall cells. 
Therefore, it is believed that with the combination of optimal stent design 
and drug coating, effective vascular stents may be achieved [25]. This 
work is focused on the optimisation of stent design for specific lesions. 
Before going further, it is important first to understand the effect that stent 
design has on restenosis given by clinical studies as discussed in the 
next section. 
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2.6 Impact of Stent Design on Restenosis (Clinical Evidence) 
Although a wide variety of stents are currently being used, an ‘ideal stent’ 
having no adverse effects still does not exist. As discussed in the 
preceding section in detail, the two most common problems that may 
arise after stent implantation are in-stent restenosis, and stent 
thrombosis which is the formation of blood clot inside the target area.  
Several clinical studies [26–29] have concluded that in-stent restenosis 
is correlated with the vessel injury caused during stent implantation. 
Hoffman et al. in a clinical study suggested that balloon expansion of a 
Palmaz-Schatz stent was related to neointimal hyperplasia due to the 
techniques aggressive nature [30]. Kornowski et al. showed in their study 
that neointimal formation after stenting was dependent on both arterial 
injury and inflammatory reaction [31].  
Rogers et al. carried out a clinical study of two different types of steel 
stents deployed in rabbit iliac arteries. They concluded that the stent 
having 29% less strut-strut intersections than the other, without affecting 
mass or surface area, reduced vascular injury by 42%, thrombosis by 
69% (platelet adhesion), and neointimal hyperplasia by 38% [32]. In their 
investigation the stent types they used were slotted tube and corrugated 
ring as shown in Figure 2-9. The corrugated ring type had 29% fewer 
strut-strut connectors. 
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Figure 2-9: Scanning electron photomicrographs of stents of different configurations: Slotted tube 
stent before (a) and after (b) expansion; corrugated ring stent before (c) and after (d) expansion. 
Original magnification x100. [32] 
The higher incidence of adverse effects associated with the slotted tube 
stent, as compared to the corrugated ring, was mainly due to vascular 
injury imposed on the arterial wall by this design. Figure 2-10 shows the 
difference between the injury score of these two designs under 
investigation. Polymer coating was also tested for these designs but the 
stent configuration exhibited the main effect. 
 
Figure 2-10: Bar graph shows vascular injury score per arterial cross section 14 days after balloon 
injury and implantation of steel stents or after balloon injury alone. Statistical analysis showed a main 
effect of stent configuration but not of stent coating [32]. 
Other clinical studies that focused on stent geometry [5,33] have 
concluded that the strut thickness especially, is a key indicator of 
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restenosis rates. In addition to that, a review article by Morton et al., who 
conducted a series of randomised trials, suggest that stent geometry 
plays an important role in determining a stent’s resistance to restenosis 
[34].  
Rittersma et al. carried out a study including 663 patients, dividing them 
into two groups. 287 patients were treated with a thin-strut stents (50 m) 
and 376 patients with thick-strut stents (>90 m). The patients treated 
with thin strut stents had significantly less late luminal loss than those 
with thick strut stents. Strut thickness was found to be an independent 
predictor of restenosis in this study [35]. 
Sommer et al. conducted a study by placing two stent types i.e. crown 
and wave, in rabbit iliac arteries. In their study they found out that wave 
stents, where the main axis of struts runs with the blood flow, optimises 
the flow profile and improves stent endothelialisation which is important 
for avoiding in-stent thrombosis and subsequent neointimal proliferation. 
They also suggested that strut thickness also reduces the risk of 
restenosis [36]. 
Similar studies in the field of arterial hemodynamics [37–39] and stented-
vessel hemodynamic [40] have shown that areas of maximum intimal 
thickening correlate with areas of low wall shear stress. 
The above mentioned clinical studies clearly show that altering stent 
geometry can potentially lead to both reduction of arterial injury and better 
hemodynamic response in order to reduce restenosis rates. 
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2.6.1 Materials 
In terms of materials, a variety of stents are available commercially. 
Materials selected for stents must exhibit corrosion resistance and 
biocompatibility [41]. Stent materials normally depend upon its bio-
compatibility and expansion type i.e. self-expanding or balloon 
expandable. Balloon expandable stents are made from material that can 
plastically deform when expanded through balloon inflation. They would 
have ideally low yield strength to make it easily deformed through 
manageable balloon pressure and high elastic modulus for minimum 
recoil due to plaque [41]. After expansion, they remain in that position 
while the catheter is removed. These stents are manufactured in a 
crimped sate (Figure 2-11). The most common materials for balloon 
expandable stents are stainless steel 316L and nitinol (shape-memory 
alloy) for self-expanding stents [41]. 
 
Figure 2-11: Examples of balloon-expandable stents. A: Endeavor (Medtronic), B: Taxus Liberte 
(Boston Scientific), C: Promus (Boston Scientific), D: PRO-Kinetic (Biotronik) [14]. 
Self-expanding stents are made from materials that can recover to their 
final shape by removal of external constraints. These stents are 
manufactured in their expanded state. Ideally, these stents should have 
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low elastic modulus and high yield stress for large strains [41]. They are 
compressed on a delivery system and upon reaching the diseased site, 
spring-back to the pre-set diameter when released from the delivery 
system (Figure 2-12).  
 
Figure 2-12: Examples of self-expandable stents. A: Wallstent (Boston Scientific), B: RX Acculink 
(Abbott Vascular), C: Xact (Abbott Vascular), D: SelfX (Abbott Vascular). 
The characteristics of an ideal stent have been described (Figure 2-13 &  
Table 2-3) in numerous reviews [42–45]. 
 
Figure 2-13: Characteristics of an ideal stent [15]. 
Ideal 
Stent
Manufacturable
Drug Delivery 
Capacity
Sufficient radial  
strength
Biocompatible
Good Expandibility 
Ratio
Radiopaque
Flexible
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Table 2-3: Materials with ideal characteristics for coronary stent applications [46]. 
Properties Material Rationale 
Elongation modulus 316L stainless 
steel 
Optimal value for a balloon 
expandable stent 
Tensile strength Co–Cr Higher value 
Yield strength Co–Cr Much lesser when compared 
to its own tensile strength 
Surface energy PTFE Lower value 
Biocompatibility Ti Extensive literature  
Presence of stable oxide 
layer 
Surface potential Ta Stability of surface oxide 
layer 
Stability of surface 
oxide layer 
Ta/Ti Excellent stability among the 
implant materials 
Therapeutics Paclitaxel Hydrophobicity 
Radiopacity Gold High density 
MRI compatibility Ta/Ti/Nitinol No Fe content 
Preferred way of drug 
loading 
Polymer based Amount of drug can be 
increased to the need just 
by increasing the thickness 
of the coating 
Preferred way of drug 
elution 
Biodegradable No polymer material will be 
present once the process is 
finished 
Preferred category of 
polymers 
Biopolymers Minimal inflammatory and 
hypersensitive reactions 
2.6.1.1 Metallic Stents 
Several metals are being used for coronary stents, the most common 
being stainless steel 316L, due to its corrosion resistance, suitable 
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mechanical properties and affordability [41]. However, 316L SS has poor 
fluoroscopic visibility and is a non-magnetic resonance imagining (MRI) 
compatible material, due to its ferromagnetic nature. Other metals 
include platinum-iridium (Pt-Ir) alloy, tantalum (Ta), cobalt-chromium  
(Co-Cr) alloy, nitinol (Ni-Ti), pure iron (Fe), titanium (Ti) and magnesium 
alloys [46]. Stents that are made of metals only are known as bare metal 
stents (BMS). In 2002, a new field of drug-eluting stents (DES) was 
introduced, having an active drug coating to reduce in-stent restenosis. 
These DES typically consist of three components: a metallic stent 
platform, a polymer coating, and the drug itself stored within the coating 
[47]. After implantation, the coated drug is slowly released from the 
coating to the injured vessel wall (Figure 2-14). 
 
Figure 2-14: (A) The NEVO cobalt chromium stent, which has an open-cell design and unique 
reservoirs that contain a biodegradable polymer and sirolimus mix that (B) completely biodegrades 
within 90 days [16]. 
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2.6.1.2 Polymer Stents 
Mani et al. [46] have described in their study that polymer stents can be 
broadly classified into four groups i.e. biodegradable polymers, bio-stable 
(non-biodegradable) polymers, copolymers and biological polymers. 
Silicone was the first polymer to be used as a stent; unfortunately it has 
poor mechanical properties [48]. Other polymers that have already been 
tested for stents include polyethylene terephthalate (PET), Poly-L-lactic 
acid (PLLA), and poly-L-glycolic acid (PLGA) [46]. Like metallic stents, 
polymer stents should also be biocompatible and have sufficient 
mechanical properties for providing stable support to the diseased 
vessel.  
2.6.1.3 Biodegradable Stents 
Permanent metallic or polymer stents including DES have improved the 
outcomes of coronary angioplasty. However, their permanent presence 
as a foreign body in the arteries may induce complications in the long 
run, such as late stent thrombosis and vascular inflammation, although 
their scaffolding function is only required for a number of weeks [49]. 
Therefore, a new area of metallic and polymer based biodegradable 
stents has emerged, which are commonly referred to as scaffolds. These 
scaffolds can disappear with time after supporting the diseased vessel 
for a defined period. The other main advantage is that anti-inflammation 
drugs can be released through these stents in a controllable manner [46]. 
In metals, pure iron and magnesium alloys have previously been used 
successfully as biodegradable stents in rabbit and porcine arteries, but 
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these stents are prone to fracture because their yield strength is close to 
their tensile strength [50–52]. In polymers, the first biodegradable stent 
was developed by Stack et al. made of Poly-L-lactic acid (PLLA) and 
implanted in a canine model. Limited thrombosis and minimal neointimal 
proliferation was noticed in the short term and also at 18 months [53]. In 
humans, Igaki-Tamai was the first fully biodegradable stent to be 
deployed and was made of PLLA without any drug coating. However, it 
didn’t become renowned due to its contrast heating requirement (70-
80°C) during deployment to fully cure and shape-form the stent, that 
could potentially adversely affect the artery [49]. Other polymers, such as 
Poly-L-glycolic acid (PLGA) and polyurethanes (PU) have been widely 
used in drug delivery devices, bioresorbable sutures and orthopedic 
implants and are the most investigated polymers for coronary stents. In 
terms of drug delivery, the behaviour of PLGA is important due to its 
controllable degradation [54]. Figure 2-15 shows some of the metallic and 
polymeric biodegradable stents currently in use [49]. 
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Figure 2-15: A variety of metallic (AMS1, DREAMS 1) and polymeric biodegradable stents currently 
used in clinical practice [49]. 
2.6.2 Fabrication Methods 
Stents are generally made from laser cut hollow tubes and braided or 
welded wires. Other methods include photochemical etching and knitting 
[41]. The most preferable production method is laser cutting due to its 
reliability, ability to cut complex geometries and quicker processing times 
[55]. Stoeckel et al. have described in their survey that the choice of 
fabrication method depends mainly on the raw material form used [41]. 
Coil stents have the simplest geometry and are made from winding wires 
in the form of a spring. Open and closed cell designs could be made by 
welding wires at different places to form sinusoidal rings. Similarly, 
knitting the wires could produce flexible self-expanding or balloon 
expandable stents. Balloon expandable stents are generally fabricated in 
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the crimped state and post processed with deburring and surface 
treatment, mainly electropolishing. On the other hand, self-expanding 
nitinol stents are normally made in the expanded shape and constrained 
in the delivery system. Laser cutting also results in a heat affected zone 
(HAZ) along the cutting edge which is later removed for better outcomes. 
In comparison to laser cutting, water jet cutting doesn’t produce HAZ. A 
focused water jet is directed at the target metal with some abrasive 
additives to cut the desired pattern instead of a laser beam. 
Photochemical etching is another way of producing stents and has been 
demonstrated to be a suitable method for making magnesium-alloy 
stents [56]. Some of the advantages and disadvantages of the above 
manufacturing methods are given in  
Table 2-4.  
Table 2-4: Advantages and disadvantages of stent manufacturing methods [41,57,58]. 
Fabrication Advantages Disadvantages 
Laser Cutting 
Intricate patterns, able to process 
smaller diameter tube, reliable, fast, 
high precision and low cost.    
(vastly used) 
 
Heat effects 
Welding 
Adjustable flexibility and wide range 
of size and length 
Radial strength is usually 
less than the ones 
processed with laser cutting 
Braiding, Knitting Simple process, adjustable flexibility Slow process 
Photochemical 
Etching 
Large number parts can be 
processed in a single run, complex 
patterns can be produced 
Requires extremely clean 
operating conditions 
 
Additive 
Manufacturing (AM) 
 
Can potentially make customised 
stents, multi-material printing, high 
resolution profile [59] 
(Not commercialised or tested yet) 
Mechanical properties may 
not be comparable to laser 
cut, poor surface due to 
layered fabrication and 
sintering of particles from the 
build area [59] 
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2.6.3 Geometry 
Since the introduction of stents more than 30 years ago, a variety of 
different geometries have evolved to improve mechanical properties such 
as radial strength and flexibility. Early stents were made in the form of 
coils or slotted tubes. Slotted tubes designs such as Palmaz-Schatz were 
known for its strength but lacked flexibility, which is important when it 
comes to delivery in curved vessels. Later designs consisted of repetitive 
sinusoidal rings each known as a cell or unit. In a design review, Stoeckel 
et al. have categorised stent geometries into five different types i.e. Coil, 
Helical Spiral, Woven, Individual Rings or Sequential Rings, with each 
having sub-types [41]. Coil stents are usually made for non-vascular 
applications such as tracheobronchial and prostatic obstructions. They 
are extremely flexible but have limited radial strength. Figure 2-16 is an 
example of a coil stent design. 
 
Figure 2-16: Esophacojl. Coil stent fabricated from nitinol ribbon [41]. 
Helical spiral designs are generally flexible with no or few internal links 
but lack longitudinal stiffness. Therefore they can be compressed or 
elongated during implantation, and ultimately result in irregular cell size. 
Figure 2-17 shows a Crossflex stent having a minimally connected helical 
spiral design. 
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Figure 2-17: Crossflex. A minimally connected helical spiral stent fabricated from stainless steel wire 
[41]. 
Woven stent designs are fabricated from one or more strands of wire. 
Braided wire geometries are often used for self-expanding stents, but the 
drawback with these designs is that they typically shorten substantially 
during expansion. The radial strength of these designs mostly depends 
upon how the ends are fixed. Figure 2-18 illustrates the Cook ZA stent, a 
self-expanding knitted nitinol wire stent. 
 
Figure 2-18: Self-expanding knitted Nitinol wire design [41]. 
Most modern commercially available stents are made up of two main 
parts: rings and links; the former plays a vital role in providing radial force 
while the latter mainly is there for flexibility and structural stability [34]. 
The rings normally have a series of repeated Z-shaped elements known 
as struts joined by connecting links or bridges. This category of stents 
could be further divided into two main types i.e. open and closed-cell 
designs depending upon how the individual rings are linked. 
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Open-cell designs have minimal links between the rings in a defined 
pattern compared to closed-cell where all inflection points are connected 
by links and hence exhibit less flexibility than the closed-cell designs. 
Figure 2-19 shows some of the possible strut configurations. 
 
Figure 2-19: Strut configuration: open cell (a), closed cell: Non-flex connectors (b), flex-connectors (c), 
combined flex/non-flex connectors (d). 
A variety of combinations could be formed by introducing links connecting 
struts at different locations. Peak to peak connection is used to describe 
rings connected to each other via the outer radius of the inflection points. 
Similarly in peak to valley connection, the outer radii of ring inflection 
points are bridged to the inner radii of the adjacent ring inflection points. 
Other types include mid-strut to mid-strut connections. The shapes of the 
links also vary; designs have improved flexibility by adding N, S, U and V 
type flex connectors [41].  
 
Figure 2-20: Palmaz-Schatz slotted tube type stent [41]. 
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The Palmaz-Schatz stent is an example of closed-cell design, having the 
main advantage of optimal scaffolding and a uniform surface (Figure 
2-20). Later designs such as the NIR stent has improved flexibility due to 
‘V’ type links as shown in Figure 2-21. 
 
Figure 2-21: NIR stent with 'V' type flex connectors [41]. 
2.7 Finite Element Analysis in Stent Design 
Finite element analyses (FEA) of stent design are very useful tools for 
evaluating the performance of stents and can be used alongside 
experimental studies to optimise stent designs. In addition to being cost 
effective, computational analysis also enables estimation of the arterial 
wall stresses and behaviour in reaction to stent implantation, therefore 
providing insights into different aspects of stent geometry that may 
improve the final outcome. 
Numerous studies have employed FEA to look at various stent 
geometries and determine the patterns of arterial wall stress that they 
induce. These studies allow us to understand the mechanics of stent-
artery interaction [60–62] and the influence of several different stent 
geometry variables such as stent strut thickness [62,63] and plaque 
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composition [64,65]. Other studies have investigated and compared 
commercially available stents [66,67] and generic designs [68].  
One of the pioneering studies of stent geometry parameterisation among 
the above discussed studies was of Migliavacca et al. [60]. In their study 
they carried out a parametric analysis by varying different features such 
as strut thickness, slot length and metal/artery index to evaluate the 
mechanical performance of a slotted tube stent design. They concluded 
that a stent with lower metal to artery ratio will exhibit higher radial and 
longitudinal recoil but a lesser degree of ‘dog-boning’ (excessive 
expansion of stent ends). Similarly, strut thickness also plays an 
important role in the expansion profile. They also conducted experiments 
on stent expansion and observed the deformation under scanning 
electron microscope, which were in close agreement with the 
computational model. 
Bedoya et al. [68] investigated the interaction of an artery with a 
parametric stent model. In their study, stents were defined by three 
geometric parameters: strut spacing (h), radius of curvature (ρ), and axial 
amplitude (f), illustrated in Figure 2-22. They reported that stent designs 
having large strut spacing, a non-zero radius of curvature, and large 
amplitude induced lower stresses on the artery. 
 
 
 
33 
 
 
Figure 2-22: Design parameters. Generic stent showing the three parameters of interest: h is the 
connector bar length (or strut spacing), ρ is the radius of curvature at the crown junctions, and f is the 
axial amplitude. These three parameters were varied to test their effects on artery wall stress [68]. 
Stent expansion during deployment plays a crucial role in the 
biomechanical environment and significantly influences restenosis. Two-
dimensional linear elastic models have been employed by Rogers et al 
[69] to investigate balloon expansion with stent and artery contact. 
Results of that study show that high inflation pressures, wide stent-strut 
spacing and more compliant balloon materials cause larger surface-
contact areas and contact stresses between stent struts. It was reported 
that stent design and deployment methods play a vital role in stenting 
outcomes. A similar interesting study was carried out by Mortier et al. [70] 
in which they investigated the effects of balloon folds and placement 
during stent implantation. Their results showed that the number of balloon 
folds and position with respect to the stent can greatly reduce the 
dogboning effect which in turn influences the artery. Chua et al. [71] also 
looked at a stent design similar to a Palmaz-Shatz stent with five different 
strut and slot sizes to investigate the stress distribution, deployment 
pressure, elastic recoil and foreshortening. They found out in their study 
that increasing slot size is better than strut width to achieve a higher 
expansion rate without significantly impacting foreshortening. 
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A number of other studies have focused more on the stresses imposed 
on the artery wall. Lally et al. [67] modelled the stent-artery interaction of 
commercially available stents (NIR-Boston Scientific; S7-Medtronic AVE) 
on an idealised stenosed artery. Their results showed that the modular 
S7 stent design causes lower stress to an atherosclerotic vessel with a 
localised stenotic lesion compared to the slotted tube NIR design. These 
results correlated well with the clinical restenosis rates associated with 
respective stents. The testing methodology is proposed as a preclinical 
testing tool, which could be used to compare existing stent designs as 
well as help in developing novel stent designs. Appendix A presents an 
overview of selected clinical and FEA stent analysis studies. 
2.8 Structural Optimisation 
Before describing  stent design optimisation studies, this section provides 
a background and main types of structural optimisation methods. 
According to Gottfreid and Weisman (1973) optimisation is defined as “an 
art of obtaining best policies to satisfy certain objectives at the same time 
satisfying fixed requirements”. This definition is found to be applicable in 
a wide variety of fields such as finance, engineering, biomedical 
applications and energy [72,73]. In terms of structural engineering, 
optimisation aims to achieve the best performance for a structure that 
can sustain service loads while satisfying certain design constraints such 
as a given amount of material [74]. The ‘best performance’ is normally a 
measure of mechanical properties of the structure, although other 
functionalities and aesthetics may also influence the design selection.  
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From a mathematical point of view, optimisation aims at finding the 
maximum or minimum of an objective function such that the convergence 
criteria and all the specified limiting values or constraints are satisfied. 
That is achieved by changing the values of design variables. The 
minimum or maximum optimal points of an objective function are called 
optima. Optima could be local or global depending upon the complexity 
of the function. Figure 2-23 shows local and global optima for a given 
function, where it is evaluated in an interval [x1, x5] known as the design 
domain. 
 
Figure 2-23: Local and global optima. 
In most cases, the global optimum is desired but it may be hard to achieve 
or may not exist especially in nonlinear optimisation. For example 
gradient-based approaches may struggle to find the global optimum and 
are likely to get stuck in local optima. Stochastic based algorithms on the 
other hand aim to increase the probability of finding the global optimum.  
Over the past few decades, due to the advancements in computational 
speeds and algorithms used in design optimisation, a growing number of 
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engineers and architects have started to experiment with and benefit from 
design optimisation for a variety of fields including biomedical 
applications.  
The first step towards solving an optimisation problem is to adequately 
formulate the problem by carefully selecting the desired objective 
function that needs to be maximised or minimised. Depending upon the 
requirement, the objective could be a structural response such as 
displacement, stiffness, force, strain or minimisation of weight of a 
component etc. The design variables and constraints are then specified. 
The aim is then to determine the optimal values for the design variables. 
An example of an optimisation is given below. 
Objective:     𝑀𝑖𝑛 𝒇 (𝒙)     5.1 
Design variable:             𝒙 = (𝒙𝟏, 𝒙𝟏, 𝒙𝟏 … , 𝒙𝒏)
𝑻       5.2 
𝒙 ∈ 𝑿 ⊂ 𝕽𝒏      5.3 
Constraints: 
𝒈(𝒙) = 𝟎     5.4 
𝒉(𝒙) ≤ 𝟎     5.5 
where 𝒇 (𝒙) is the objective function, 𝒙 is the design variable which 
belongs to a subset 𝑿 of the n-dimensional real space 𝕽𝒏. Equations 5.4, 
5.5 represent equality and inequality constraints respectively with 𝒈(𝒙) 
and 𝒉(𝒙) being the constraint functions. 
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For structural optimisation, MSC Nastran uses design sensitivity analysis 
that computes the rate of change of structural responses with respect to 
the changes in the design variables. It links finite element analysis with 
numerical optimisation. Once a new design has been proposed in a 
design cycle the next step is to evaluate the new design to determine if it 
has achieved its objective function within the given constraints. Figure 
2-24 describes the optimisation steps MSC Nastran uses. 
 
Figure 2-24: MSC Nastran implementation of structural optimisation [75]. 
Structural optimisation can be broadly categorised in three areas, i.e. 
size, shape and topology optimisation. Size optimisation is the earliest 
approach and deals with finding the optimal design by changing the size 
of structural features such as cross-section of truss or thickness of plates 
[76]. Shape optimisation is mainly to modify predefined boundaries of 
 
 
38 
 
continuum structures to find optimal design. Topology optimisation (TO) 
is to find the optimal spatial distribution of material and connectivity of 
structural elements [74]. In other words, the goal of topology optimisation 
is to find the best use of material of a structure that is under either single 
or multiple load scenarios.  
Before discussing structural optimisation techniques used for stent 
applications, an overview of each of these optimisation types is presented 
as follows [77]. 
2.8.1 Sizing Optimisation 
Sizing optimisation is commonly applied to a truss type structure to obtain 
the optimal cross-sectional areas of beams. In this case the sizing design 
variable would be the beam's cross-sectional area, but frequently the 
material thickness of a plate or sheet is also used. The approach has 
been successfully applied to the structural design optimisation of wind 
turbine towers by Negm & Maalawi [78], where the cross-sectional areas 
of tower segments were used as sizing design variables. A schematic 
example of sizing optimisation applied to a truss structure can be seen in 
Figure 2-25. 
 
Figure 2-25: Size optimisation of a truss structure [77]. 
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2.8.2 Shape Optimisation 
Shape optimisation is more advanced than sizing optimisation in that it 
determines the optimal boundaries of a structure for a given fixed 
topology. Design variables are typically geometric parameters, such as 
spline control points, defining the shape of a structure in either. A shape 
optimisation technique has been applied by Rispler et al. [79] in the 
design of adhesive fillets, by Waldmane et al. [80] in the design of 
shoulder fillets in flat plat plates, and by Jones et al. [81] in the design of 
holes in plates for the consideration of fracture strength. In each of these 
cases, spline control points were used as design variables in order to 
alter each shape boundary. A schematic example of shape optimisation 
is shown by Figure 2-26. 
 
Figure 2-26: Shape optimisation of a truss structure [77]. 
2.8.3 Topology Optimisation 
Both sizing optimisation and shape optimisation, however, has a 
disadvantage of being completely dependent on the initial structure and 
are therefore unable to introduce additional holes within the structure for 
the purpose of reducing weight. Topology optimisation (TO) was 
developed to overcome this deficiency and is consequently a much more 
powerful design tool. In theory, topology optimisation is capable of finding 
the best material distribution within a design space, independent of the 
initial starting design structure [77]. This allows these methods to be used 
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earlier in the design process (at the conceptual stage) before the design 
is heavily constrained, compared to either sizing or shape optimisation. 
As with shape optimisation, topology optimisation causes changes to the 
FE model and therefore requires increased computation. A schematic of 
topology optimisation applied to a simple beam can be seen in Figure 
2-27. 
 
Figure 2-27: Topology optimisation of a truss structure [77]. 
Typically the given design domain is initially discretised into a mesh of 
finite elements and is then solved to obtain a structure consisting of solid 
and void regions based on the optimisation results. Figure 2-28 illustrates 
the general scheme of TO where a force F is applied to a structure with 
a given initial design domain Ω. Ωv and Ωs represents the resulting void 
sub-domain and solid domain respectively. 
 
Figure 2-28: General scheme of topology optimisation. 
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Out of the three structural optimisation sub-categories, topology 
optimisation offers the greatest opportunity for creating novel designs as 
a result of it being completely independent of any initial design, unlike 
both sizing and shape optimisation which rely on an initial design as a 
starting point. Although topology optimisation has been used rarely for 
stents, it can be used to produce novel designs. 
The finite element method and optimisation are useful tools for designers 
to analyse different loading conditions and design parameters of stents 
to improve the outcome of stenting procedure and reduce the adverse 
effects associated with it. As described earlier, one of the most serious 
problems with the stenting procedure is the suboptimal deployment of 
stents which may occur due to high contact forces from different types of 
diseased arteries. The geometry and stiffness of an atherosclerotic artery 
varies due to plaque shape and material properties. As a result it applies 
variable loads longitudinally on an implanted stent. Because of improper 
stent design, it may recoil due to higher radially compressive force, which 
leads to unacceptably low lumen area and non-ideal lumen shape. There 
are no specific rules or guidelines in the literature to design an ideal stent 
and most commercially available stents are largely developed and 
experimentally tested using a “trial-and-error” approach. Although many 
studies have been carried out to improve the typical rings-and-links stent 
design, TO has not been used to develop a full length stent for lesion-
specific environment. TO has the ability to provide stent design concepts 
with optimal material distribution for different plaque types and is utilised 
in this work.  
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TO is often used at conceptual design stage and is usually post-
processed to meet the manufacturing requirements. The most commonly 
used strategies to solve TO problems are the homogenisation method 
[82,83], the evolutionary structural optimisation (ESO) method [84,85] 
and the density or solid isotropic material with penalisation (SIMP) 
method [77]. In the ESO method, an iterative material removal of material 
is involved which is achieved by either reducing the stiffness of elements 
or entirely removing them from the design domain. ESO in essence, 
creates takes the design towards an optimal state by keeping the efficient 
elements and removing the inefficient elements.   In the homogenisation 
method, each unit cell of a structure is imagined to be made of a 
composite material with microscale voids or holes to form a porous 
medium. The optimisation problem is then solved for the optimal porosity 
of the structure. This is achieved thorough determining the optimum 
parameters of holes in each cell such as size and orientation. The porous 
nature of the method made it difficult to produce it via traditional 
manufacturing method. This idea was further developed into a simpler 
approach now commonly known as SIMP where optimal mapping of an 
isotropic material is determined. The structure is allowed to have a 
continuous representation of element densities and a single variable is 
required per element as opposed multiple with the homogenisation 
method. This method is known as soft-kill compared to the hard-kill 
method employed by ESO. SIMP is simpler and a powerful TO algorithm 
and is extensively used in commercial software. It will be used in this 
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thesis to optimise stent design and is described in the subsequent 
section. 
2.9 Solid Isotropic Material with Penalisation 
The SIMP method was first proposed by Bendsøe in 1989, it is also 
known as the density or power law method. The basic concept of this 
method is that each variable in a given structure is assigned a density 
value, which is used as the design variable in the optimisation. Elemental 
densities are increased in places where the strain energy is higher and 
decreased in regions where it is lower thereby creating a new stiffness 
distribution in the structure [86]. The density variable is denoted by ρ, and 
to penalise the intermediate densities to obtain a discrete solution, a 
penalty factor is introduced to make elements with intermediate densities 
less favourable in the optimisation. The penalty factor can increases the 
efficiency of the results by inhibiting elements with intermediate densities 
and therefore producing an optimised structure with mostly solid or void 
elements. No elements are removed in this method. In the SIMP method, 
the elastic tensor is defined as: 
𝑬(𝑥) = 𝑥𝑝𝐸𝑖𝑗𝑘𝑙
0 ,  𝑝 > 1    5.6 
𝑉 = ∫ 𝑥𝑑ΩΩ      5.7 
where 𝑥 is the design variable of each element with volume density 
ranging 0 ≤ 𝑥 ≤1, Ω is the structural design domain for optimisation, 𝑝 is 
the penalty factor and the volume 𝑉 is evaluated as its integral over the 
design domain. In MSC Nastran, the penalty factor is always greater than 
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1 and values typically used are 3 for solid elements and 2 for shell 
elements. Figure 2-29 and the list below illustrates the steps during SIMP 
topology optimisation for compliance minimisation for a given volume 
fraction. 
a) All elements of the design domain are assigned a homogenous 
density distribution initially. 
b) FEA is carried out for the obtained density distribution resulting in 
nodal displacements. During the iterations, the density variables 
are updated based on the previous iteration. 
c) Compliance is evaluated and the change in compliance with 
respect to the objective function is monitored. 
d) The optimisation ends if the change in compliance is small based 
on the convergence criteria. 
e) The results are post processed by specifying a density threshold. 
Upon completion of the optimisation iterations, the output results consist 
of elements with densities ranging from 0 to 1. MSC Patran allows post 
processing to produce structures with smoothed boundaries. 
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Figure 2-29: General process flow of topology optimisation using SIMP. Adapted from Lee 2011 [87]. 
2.10 Optimisation of Stent Design and Lesion-Specificity 
Although being very limited in the literature, computational models 
focusing on the optimisation of stent geometry offer effective solutions to 
address some of the important challenges such as achieving the 
desirable stent geometry features that reduce the risk of restenosis. Wu 
et al. [88] conducted a shape optimisation study to increase the 
scaffolding ability of biodegradable magnesium stents by effectively 
increasing the strut width, also extending its expected degradation time. 
Stress concentrations in stent geometry are also crucial to consider in the 
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design to develop stents with improved fatigue life. Abad et al. [89] used 
shape optimisation to achieve a design with superior fatigue life.  
As explained earlier, expansion of a stent during implantation in an artery 
is very important with regards to the overall outcome of the treatment. A 
number of studies have looked at the expansion of stents under different 
loading conditions. In terms of optimisation, Wang et al. [61] studied the 
effects of strut cross-section size of two different stent designs on stent 
expansion and concluded that dog boning and foreshortening could be 
reduced by altering the strut at the end rings. Beule et al. [90] carried out 
optimisation of braided wire self-expanding stents and achieved a design 
with reduced foreshortening by 20% while maintaining radial stiffness but 
without considering artery or plaque in the investigation. Li et al. [91,92] 
used a single weighted objective function based on a parametric model 
in their optimisation to minimise dog-boning, foreshortening and recoil of 
a commercial stent. They concluded in their investigations that dog 
boning may be avoided by effectively manipulating strut length of the cells 
on either sides of the stent, varying from the length of struts in the central 
part of the stent. Pant et al. [93,94] further extended these studies into 
multi-objective optimisation of stents incorporating recoil, volume 
average stress in the arterial tissue, flow index, drug distribution and stent 
flexibility. They used three geometric parameters (strut thickness, ring 
amplitude and link height) to optimise these objectives. A non-dominated 
sorting genetic algorithm (NSGA-II) was used to search for the optimal 
family of designs and a number of trade-offs between the objectives were 
identified. Clune et al. [95] used non-uniform rational basis spline 
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(NURBS) to parameterise stent design to optimise the shape of a single 
repeating cell of the stent rings in order to achieve better fatigue 
resistance. Taking a multi-objective optimisation approach, they 
successfully generated a Pareto front to represent the trade-off between 
fatigue resistance and flexibility. 
Li et al. [96] used an optimisation method combined with kriging surrogate 
model to develop the approximate relationship between optimisation 
objectives and design variables for optimal stent expansion. While 
simulating free expansion of a balloon expandable stent, they kept stent 
dogboning as the performance factor. They were able to demonstrate 
improved fatigue life of two selected stent designs (diamond-shaped and 
sv-shaped) as a test case while eliminating the dogboning phenomenon. 
Kriging surrogate model, a relatively recent phenomenon, is a semi-
parameter interpolation technique and is widely used in multi-disciplinary 
design optimisation. 
In another recent study, Puértolas et al. [97] developed a methodology 
for patient-specific nitinol colonic stents to alter the behaviour to achieve 
variable radial stiffness along its longitudinal axis by a parametric 
analysis of design features such as diameter, slot length, the number of 
circumferential slots and tube thickness. With their method, they were 
able to approximate the mechanical behaviour of stents, such as the 
radial expansion force, in different sections to aid customised designs.  
Pant et al. [93] and Amirjani et al. [98] carried out FEA and CFD analyses 
to generate a range of multi-disciplinary objectives. Amirjani et al. [98] 
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defined an aggregate objective function which combined 
mechanobiological response such as arterial wall stress with stent recoil 
and flow induced shear stress. Generally, with any stent design, 
objectives such as stent recoil, arterial stress and flexibility are in 
competition such that improvement in one objective results could result 
trade-off in others. Pant et al. [93] used stent recoil and flexibility with a 
drug elution metric in a constrained optimisation study in which optimised 
designs were obtained for each metric relative to a base line geometry 
without diminishing any other metric. 
The above discussed optimisation studies do not take into account 
different plaque geometry and composition. A more realistic approach 
was adopted by Timmins et al. [65] by taking different plaque 
compositions with two different stent designs to examine the solid 
mechanical effects of varying stent design and plaque composition on the 
biomechanical environment in their analysis. In their study they used two 
generic stents, one stiff and the other less stiff, similarly choosing plaque 
stiffness as more, less and equally stiff as the artery (Figure 2-30). They 
concluded that the selection of stent geometry for specific lesions is vital 
to minimise the injury inducing stresses in the artery. Further investigation 
is needed to tailor the stent design according to the required realistic 
loading conditions. 
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Figure 2-30: Two generic stent designs. Stent 1Z1 as stiff, Stent 2B3 as less stiff with un-deformed 
plaque geometry [65]. 
As described in section 2.2, with the progression of atherosclerosis, 
plaque morphology changes. This means variation in shape, size and 
composition. Composition also effects the stiffness of the plaque and 
hence alters the mechano-biological interaction with stents. Stent 
implantation in arterial environment with different shape and stiffness can 
likely yield different vascular behaviours. For instance, over-expansion of 
stent causes arterial injury, which can lead to neointimal hyperplasia [99]. 
Assessing the nature of the artery and plaque morphology therefore, is 
crucial in achieving successful stenting procedure. Plaque size and 
stiffness also vary with the progression of the disease (Figure 2-32). 
Plaques types could be mainly categorised into three types based on 
their tensile properties. Figure 2-31 depicts the stress-strain tensile data 
represented by the strain energy density functions for the three different 
plaque histological classes averaged from autopsies of 21 patients in a 
study [64]. 
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Figure 2-31: Uniaxial tensile stress–strain data represented by the strain energy density functions for 
the three different plaque types in the finite element models. Source: [64] 
 
 
Figure 2-32: Progression of atherosclerosis leading to plaque morphology change. Copyright 
Medmovie, reproduced with permission from Medmovie [100]. 
Coronary lesions have been known to be more eccentric [101], this is 
expected to yield varying compressive pressure on stents and ultimately 
impact their interaction. Which is one of the reasons that many of the 
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mentioned FEA studies [62,66,102,103] have chosen asymmetric lesions 
for their analysis.  
In addition to that, it has also been found that male and female coronary 
arteries differ in morphology. Studies [104–107] have shown that the 
main coronary arteries in women are smaller in diameter then men. 
Furthermore, plaques in women also appear less calcified. Hitesh et al. 
[106] studied gender based differences in coronary arteries of over 700 
patients, the difference in diameters was found to be 11.25% to 13.5% 
larger in males vs females, depending upon the type and location of 
coronary artery. There was no significant relationship between coronary 
artery diameter and other clinical factors such as age, race, weight, 
height, cholesterol, diabetes, hypertension, family history and smoking. 
As gender significantly influences artery diameters and nature, this 
warrants gender and patient-specific approaches for stent design and 
treatments. 
Although many groups have researched biomechanical characters of 
stents using finite element methods [63,65,68,94,108], topology 
optimisation has been rarely explored in patient-specific stent design 
fields. Wu et al. [109] conducted a study to topologically optimise the 
stent struts (Figure 2-33), with a pre-defined overall stent topology, for 
drug holding capacity while increasing the strut stiffness and keeping in 
view the manufacturing constraints. 
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Figure 2-33: (a) Illustration of the Conor stent with the opened configuration, which is composed of 
honeycombed strut units joined by flexible links. (b) One strut isolated from the stent unit. (c) The 
strut model meshed in OptiStruct without holes, yellow part being the design domain for 
optimisation. (d) The element density distribution with MMS of 0.042mm at the iteration number of 
30 [109]. 
Another topology optimisation study looked at creating stent cell design 
for flexibility and hardening separately [110]. It was demonstrated that it 
is possible to design stent cells using the topology optimisation 
technique. Although the resulting topologies were significantly different 
to the commercial designs, they met the flexibility and hardening criteria. 
The final geometry of a diseased artery after stent implantation is of 
paramount importance. It is shown in a another study, involving self-
expanding stents [111] that lesion calcification of the arterial wall could 
lead to a more severe residual stenosis, dog boning effect and 
corresponding edge stress concentrations after stenting (Figure 2-34). 
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This ultimately could mean that the stent may not be able to serve its 
purpose to adequately prop the diseased artery. 
 
Figure 2-34: The stented artery with calcified plaque [111]. 
Zhao et al. [112,113], used a soft and a hard plaque both causing a 
stenosis of 50%. Immediately after stent deployment, 39% residual 
stenosis still existed in stiffer plaque which does not satisfy the desired 
residual stenosis standard of 30% or less.  It is therefore vital to consider 
design changes to the stent to achieve acceptable lumen diameter in 
such calcified arteries. 
Garcia et al. [103] investigated the design of a variable radial stiffness 
self-expanding stent for a carotid artery with calcified plaque. It was 
emphasised in their study that all desirable features in a stent are hard to 
achieve at the same time, therefore it is necessary to reach a 
compromise between tissue stress, stent flexibility and radial force. In 
their investigation they mainly focused on altering the strut thickness of 
the stent to achieve minimal contact pressure in the healthy region of the 
artery during expansion (Figure 2-35). 
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Figure 2-35: Variable radial force stent with struts thinned in sections C1 on either side [103]. 
This approach by Garcia et al. is a step towards customised stent 
geometries for specific lesion types. It will be more challenging when it 
comes to complex lesion geometries and stiff plaques. Therefore 
topology optimisation based on contact analysis of stent and diseased 
artery is a novel approach to take into account the accurate loading 
conditions to tailor the stent design according to specific lesions while 
maintaining vessel lumen area. 
Another important aspect of stent design consideration is its long-term 
structural integrity and fatigue life. As the heart beats, the arteries pulse 
at typically 70 times per minute (40 million times per year), which induces 
cyclic loading on the implanted stent. The US Food and Drug 
Administration (FDA) recommends that stents must be able to withstand 
10 to 15 years of pulsatile loading, which is equivalent of 400-600 million 
cycles [114]. Coronary stent fracture is relatively a rare complication of 
stent implantation [115] and can result from a complex interaction of two 
states of stress i.e. static loading after implantation including higher 
residual stresses in some regions and the second state being pulsatile 
loading [116]. It is also envisaged that bioresorbable stents or scaffolds 
(BRS), which dissolve in the body over time, may resolve this issue of 
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stent fracture [115]. BRS, also sometimes known as BVS (bioresorbable 
vascular scaffolds), represent a new era of interventional cardiology and 
is gaining further attention due to its potential benefits such as 
disappearing after the healing period and avoiding permanently caging 
the vessel [117]. 
2.11 Using additive manufacturing for design customisation 
According to the American Society for Testing and Materials (ASTM), 
additive manufacturing (AM) is the (ASTM 2792-12a): 
“process of joining materials to make objects from 3D model data, usually 
layer upon layer, as opposed to subtractive manufacturing 
methodologies." 
Another most common term to describe AM is 3D printing. AM 
technologies can be grouped into seven categories based on the material 
and process involved (ASTM 2792-12a). These categories include: 
 Binder jetting 
 Directed energy deposition 
 Material extrusion 
 Powder bed fusion 
 Vat polymerization 
 Sheet lamination 
 Material jetting 
While the above processes differ in certain aspects, common steps 
involved are illustrated in Figure 2-36: 
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Figure 2-36: Steps commonly involved in an additive manufacturing process. 
Manufacturing of truly optimised designs could be limited by traditional 
methods [118]. This is due to the inherent constraints that forces a design 
to minimise manufacturing and assembling difficulties [119,120]. AM 
could potentially achieve optimal geometries utilising the three-
dimensional freedom offered by its layered approach.  
Traditional methods are generally based on the idea of low cost for large 
production quantities, for smaller quantities where a customised outcome 
is required, these techniques can become significantly costly. AM on the 
other hand can overcome this limitation and allow mass customisation as 
tool changes are not required and hence the high cost associated is 
avoided. This benefit could be utilised for creating new customised 
medical devices and their performance evaluation. Current literature has 
not explored AM for stent design and fabrication. This method has the 
potential to create patient-specific stent design and reduce in vitro testing 
cost and time as proposed by the current work [121]. 
The method used in the current study for validating the performance of 
one of the new stent designs was selective laser sintering (SLS), which 
is a powder bed fusion method involving fusion of powder particles with 
the help of a laser beam [122]. Figure 2-37 shows a schematic diagram 
of the SLS process. 
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Figure 2-37: Schematics of the selective laser sintering process. 
Nylon 12 or polyamide 2200 is most commonly used in SLS. During the 
SLS process, after each layer of powder is deposited by the roller on the 
build platform, the laser selectively scans it based on the CAD data of the 
part. The scanned layer then descends by a distance equal to the next 
layer height that is to be deposited. This process continues until all layers 
of the part are scanned. This AM technique can produce more complex 
topologies without the need of any support structures and is hence used 
in this research. 
2.12 Summary  
From the literature review, it can be concluded that limited attempts have 
been undertaken to date to analyse stents in arteries with specific 
plaques. Different studies have focused on the parameterisation of stent 
geometry to find out its influence on the mechanical properties 
[68,71,90,92,109,110,123–125], but none has optimised stent design for 
specific disease conditions. There are a variety of stent designs available, 
each differing with regard to material, strut thickness, coating and drug 
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elution. It is known that stent varieties trigger different vascular 
behaviours and a number of desired attributes have been identified in the 
literature, including biocompatible surface material, thinner struts, 
modular design, low recoil and low material surface area [32,34,126–
128]. Stenting is not risk free and poor stent design can contribute to re-
blocking conditions, such as thrombosis and neointimal hyperplasia [5]. 
These adverse conditions mainly depend upon how the stent geometry 
interacts with the arterial surface and the resulting effects on blood flow. 
Currently stenting (stent deployment) of diseased arteries generally 
involves the use of only a set of “off-the-shelf” devices. There is a 
potential risk of suboptimal stent deployment in the some target diseased 
vessel types. As discussed in section 2.10, stenting arteries with severely 
calcified plaques can result in unacceptably low lumen area and shape.  
It has been noted that a self-expanding stents when deployed in severe 
calcified arteries could result in immediate residual stenosis [111], 
therefore design changes are needed to maintain the lumen area to 
restore the blood flow to acceptable level. 
Although many groups have researched biomechanical stent-artery 
interactions using finite element methods [65,68,103,125,129,130], size 
and topology optimisation have not been explored in the plaque-specific 
stent design fields and is the subject of investigation in this research.  
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3.  Description of Research 
Novelty 
 
 
 
3.1 Introduction 
This chapter will outline gaps found from the review of the previous 
literature and present the novelty of the work done in this thesis. The aim 
and objectives are described at the end. 
3.2 Gaps in the Research 
Currently, stenting (stent deployment) of diseased arteries involves the 
use of “off-the-shelf” devices. This lack of personalisation raises the 
potential risk of suboptimal stent deployment in the target’s diseased 
vessel. This is particularly the case when treating diseased arteries with 
severely calcified plaques, which can result in low lumen area and shape. 
It is known that with the progression of atherosclerosis, plaque 
composition and mechanical properties vary considerably and plaque 
histological types such as cellular, hypocellular and calcified have been 
found to have statistically different radial compressive stiffness [131]. It is 
envisaged that lesion properties, such as shape and stiffness will be 
necessary to create customised stents. As discussed in the previous 
chapter, it has already been demonstrated [111] that stiff atherosclerotic 
lesions result in unfavourable stent shape and low lumen area. Stent 
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design changes are therefore, important to achieve acceptable lumen 
diameter in such calcified arteries.  
Another study [103] produced a variable stiffness self-expanding stent by 
altering strut thickness at the stent centre to allow more capability to hold 
stiff plaque, although the study lacked optimisation and relied on manual 
design of the stent to a single plaque. Pericevic et al. [64] investigated 
the influence of plaque materials on a selected stent based on balloon-
expandable design and concluded that plaque type has a significant 
effect on the stresses induced within an artery which may alter arterial 
response. These studies provide the evidence of the impact of lesion 
types on the outcome of stenting procedure but have not used varied 
compression in their stent design studies. This demonstrates a need to 
develop customised stent geometries for specific lesion types. 
3.3 State of the Art & Limitations of the Current Literature 
As described in detail in section 2.10, a very limited number of studies 
have explored stent design optimisation. These studies 
[61,63,88,89,91,109,110,132,133] have investigated the effect of stent 
geometry parameters such as strut shape, size and connectivity on its 
performance mainly in terms of fatigue life, radial stiffness and tissue 
stress. For instance, Wang et al. [61] investigated a parametric stent 
design focusing on reducing dogboning during balloon expansion. They 
altered the strut width and balloon length to achieve this aim. They found 
out that increasing the strut width at the end rings of a stent and slightly 
reducing balloon length provided a way to control dogboning effectively, 
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hence eliminating the risk of arterial injury. Timmins et al. [63] went further 
to develop an algorithm to optimise stent design for by using strut 
spacing, radius of curvature and amplitude of the rings as design 
parameters. By assigning weighing coefficients to the competing solid 
mechanical concerns, such as arterial stress and lumen gain into their 
design algorithm, a unique set of parameters was identified to maximise 
lumen gain while simultaneously minimising arterial wall stress. The 
accuracy of the method was evaluated using FEA in a non-diseased 
artery. This study provides a general guideline for stent design that could 
treat different types of lesions. In other words, it enables to produce stiff 
or less stiff stent designs for a balanced stenting outcome. Wu et al. [109] 
used topology optimisation to increase the stiffness of a repeating stent 
strut unit while retaining the drug holding capacity. Li et al. [91] utilised a 
shape optimisation approach to maximise radial gain and minimise recoil 
and dogboning by employing a single objective function. Another study 
by Wu et al. [88] achieved lower principal stresses in a balloon 
expandable magnesium alloy stent using shape optimisation of a 
repeating strut unit for improved safety properties.  
In terms of investigating the effect of stenting on realistic arteries, a very 
limited number of studies [97,98,134–136] have simulated stent 
deployment. These studies have used patient derived 3D reconstructed 
arterial models for their analyses and mainly focused on evaluating stent-
artery stresses due to balloon expansion, strut coverage and vessel 
deformation. Although it is a step towards stent customisation, it does not 
consider actual lesion material properties, their corresponding 
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compressive forces and stent design optimisation. Guimarães et al. [110] 
utilised topology optimisation to generate a strut cell design for flexibility 
and stiffness seperately to mimic the implant proceduce. In another 
optimisation study Pant et al. [132] used a multi-objective function 
incorporating recoil, volume average stress in the arterial tissue, flow 
index, drug distribution and stent flexibility to advance the design with 
parameters such as strut width and height. It was demostrated that 
change in one parameter leads to improvement in one objective while 
compromising one or more of the other.  
Although attempts have been made rarely to assess the effects of stent 
deployment in varying plaque material environments [64,65,103,111], 
none of the mentioned design optimisation studies have explored stent 
geometry optimisation in varying plaque shape and stiffness conditions. 
From the literature, regarding design optimisation, the following 
conclusions could be made: 
 The great majority of stent design studies only consider size and 
shape optimisation 
 To the best of authors’ knowledge, only four stent topology 
optimisation studies, publicly available, have been carried out 
mainly focusing on single strut optimisation 
 The topology optimisation studies do not consider the effect of 
varying plaque geometry and stiffness 
 The topology optimisation studies do not investigate the full-length 
stent problem 
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It is envisaged that patient-specific stent design in true sense would not 
just involve simulating patient derived arterial models alone. Considering 
the realistic solid mechanical effects of plaque composition in each case 
will be a necessary step. The studies mentioned previously, lack this 
approach of linking actual patient specific arterial information to the 
design process. One of the reasons for this is the absence of the 
technology in the current procedures to carry out this accurately. The next 
section describes a unique approach taken by the current research to 
tackle this lack of personalisation. 
3.4 Research Novelty 
Design studies in the current literature do not consider accurately 
assessing and mapping the forces acting on stents exerted by complex 
lesions for stent customisation. Arterial assessment, current procedure 
for involve intravascular ultrasound (IVUS) that mainly relies on acoustic 
reflections to determine plaque composition [137], other methods include 
computed tomography (CT) scanning [138], cardiac magnetic resonance 
(CMR) [139,140] and optical coherence tomography (OCT) [141]. 
However, advancements in arterial imaging and sensing technologies, 
and the conversion from images to in silico models will be necessary in 
order to benefit from customisation. Researchers have developed 
stretchable polymer-electronic balloon catheters from novel materials 
containing dense arrays of sensors and therapeutic modules [142,143]. 
These catheters could be used to provide high sensitivity accurate 
information about the local arterial microenvironment such as 
temperature, material type and force exerted by lesions. In the current 
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study, this concept has been taken further by exploiting finite element 
analysis (FEA) and implanting a cylinder in silico into a set of stenotic 
arteries to extract the exact forces applied by the arteries to tailor stent 
designs using topology optimisation. The proposed future solution will 
take the following form to achieve this aim: 
 Extract patient-specific arterial composition, shape and loading 
using advanced catheters (simulated using FEA in the current 
research) 
 Utilising contact FEA and TO assess and generate customised 
designs 
With regard to material, recent studies [49,144] have suggested 
bioresorbable stents, commonly referred to as scaffolds, as a possible 
future for coronary intervention. Based on this assumption, polylactic acid 
(PLA) was chosen as the material during the design process. 
Bioresorbable stents have the advantage of natural absorption by the 
body after functioning for the required period of time. No longer being 
present in the body as a permanent implant, the risk of restenosis is 
reduced as well as allowing the artery to resume its beneficial natural 
vasomotion.  
Various approaches have been proposed for TO [82,145–152], which is 
gaining attention in a wide variety of applications. TO based contact 
analysis of stent and diseased artery is a novel approach to take into 
account the accurate loading conditions of different plaque types to 
customise stent architectures according to specific lesions while 
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maintaining vessel lumen area. Although many groups have researched 
the biomechanical performance of stents using finite element methods 
[65,68,103,129,130,153], including very limited stent TO studies 
[109,110,154], topological optimisation has not been explored in the 
plaque-specific stent design fields. This study aims to demonstrate that 
TO can be used to generate designs that enable recoil to be minimised 
even in conditions where there are strong variations in material property 
and surface topology of the lumen side of an artery, particularly in the 
axial direction. 
3.5 Aim and Objectives of Current Research 
The aim of this research is to improve lesion-specific stent designs by 
linking assumed patient data (achieved through contact FEA) to the 
design process, using finite element analysis (FEA) and optimisation 
techniques, which reduce the risk of restenosis. The main objectives in 
order to achieve this aim are: 
1. To identify and investigate the key features of stents that minimise 
adverse effects such as recoil and restenosis. 
2. To investigate stent-artery contact analyses in complex lesions 
and extract the compressive forces involved. 
3. To develop new and optimal lesion-specific stents using topology 
optimisation. 
4. Experimental validation of finite element analysis (FEA) stent-
artery simulations using mock silicone artery and additively 
manufactured stent. 
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5. To compare the performance of optimised designs with a 
conventional stent design in terms of post-implantation recoil. 
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4.  Methodology: Finite Element 
Analysis and Lesion-Specific 
Optimisation 
 
 
 
4.1 Introduction 
This chapter describes the approach taken for lesion-specific 
optimisation of stents. It introduces the steps taken for creation of a range 
of stenotic arteries and deployment of a force extracting cylinder in each 
case, which provides the basis for topology optimisation.  
To generate these numerical simulations, the finite element method 
requires a number of inputs; the model geometry of the arterial vessels, 
the material properties of the plaque, artery and stents and the 
application of appropriate loading and boundary conditions. Similarly, for 
the optimisation step, the objective function and constraints along with 
other control parameters are described in detail. 
The current work methodology involves three main steps, i.e. initial 
exploration of topology optimisation of a cylinder under arbitrary loading 
scenarios (e.g. implantation in a healthy artery), topology optimisation of 
stents in a range of stenotic arteries and finally, experimental validation 
of the computational approach taken. These steps are outlined in Figure 
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4-1. The experimental methodology is explained in detail in the 
subsequent chapter. 
 
Figure 4-1: Methodology of the current work showing three steps: (A) Initial exploration, (B) lesion-
specific stent optimisation and (C) experimental validation. 
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4.2 Selection of Element Types and Solution Methods 
Before describing the details of FEA parameters, this section briefly 
discusses the elements types and solution methods used for the current 
study. The force-extracting cylinder, generic stent and design domain for 
topology optimisation were meshed with shell elements while 8 node hex 
elements were used for the stenotic artery, details of which are described 
in subsequent sections. This approach of mixing full 3D model and 
reduced-order model has been validated by Avdeev et al. [155]. 
Choosing appropriate elements to represent a structure is an important 
consideration in FEA. As FEA is an approximation technique, with an 
increase in the number and complexity of elements, the accuracy of the 
solution increases and converges towards that which would be expected 
from an analytical solution. However, this will also increase the 
computational cost and so it is important to develop a model that is able 
to represent the actual system to the required degree of accuracy without 
unnecessary computational expense. 
There is a wide range of elements types available in commercial software 
packages that provide flexibility in modelling different geometries and 
structures. The structure to be analysed is also known as a field or 
domain and the dependent variables to be found out are known as field 
variables. Elements selected for a problem should accurately represent 
a field variable in reality. For a field variable nonlinear by nature, there 
could be two possibilities of element types: linear interpolation and higher 
order elements. Using linear elements, the element size should be small 
enough such that the nonlinear field variable can be approximated in a 
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piecewise manner. Compared to higher order elements, such as 
quadratic or cubic polynomial, linear elements are quicker to solve. 
Higher order elements will usually yield more accurate results but at the 
cost of a significant increase in complexity and computational time. A 
suitable mesh, from a numerical accuracy standpoint, is one that yields 
no significant differences between results when the mesh is further 
refined. Some of the common elements used for stent-artery analyses 
are illustrated in Table 4-1. The elements used for the current work for 
arteries were 8 node hexahedral elements, and 2D shell elements for 
stent models.  
Table 4-1: Commonly used elements for stent systems and arterial tissues. 
Used For Element Types 
 Wire stents 
 
 Stent expansion 
balloons 
 Stent crimping tools  
 Stents 
 Residing vessels 
 
 Wire stents 
 Residing vessels 
 Laser-cut stents 
 
Shell elements are usually used for a thin structure where it is in presence 
of membrane stresses combined with bending stresses. Shell elements 
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approximate a 3D continuum with a surface model and can model in-
plane deformations and bending efficiently. To determine the 
appropriateness of using shell elements for a structure, a common rule 
of thumb is if the thickness is less than 1/10th of a typical global structural 
dimension, then the use of shells are deemed to be appropriate.  
Moreover, shell elements allow curvature in space, and are sometimes 
known as 2½D elements i.e. surface elements in 3D space. However, the 
curvature must not be too great to ensure validity. The ratio of curvature 
to thickness should not exceed 5 to produce reasonable results in most 
cases. The thickness of shell elements is represented using an analytical 
model which improves the efficiency significantly compared to solid 
elements. Thin or thick shells may be used depending on the problem 
requirements. The thin shell formulation follows Kirchoff theory where 
transverse shear deformation is neglected. The thick shell formulation 
follows Mindlin theory which does account for shear behaviour [156]. 
Shell elements normally have three displacement degrees of freedom per 
node and two rotation degrees of freedom. A thin shell can be very strong 
if the membrane action dominates, which is similar to an arch when 
subjected to compression. 
Solid elements are three-dimensional finite elements that can model solid 
bodies and are commonly used when modelling arteries. The boundary 
conditions acting on solid elements are treated more realistically 
compared to beam or shell elements. A solid hexahedral element is also 
known as a hex or brick in the finite element literature and is topologically 
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equivalent to a cube. Due to the bending properties of hexahedral 
elements, stents and arteries can be modelled effectively. 
2D thin shell elements support 6 degrees of freedom, but all solid 
elements have only 3 translational degrees of freedom and no rotational 
degrees of freedom. Regarding hex meshing, it is generally 
recommended to use a minimum of 2 elements across any thickness. It 
should also be noted that with hex meshing, more effort is needed to 
prepare an appropriate mesh, and the processing time also increases 
significantly.  
In this work, the two types of aforementioned elements, hex and shell, 
were used for the diseased arteries and stents respectively. MSC Marc 
allows contact between these two element types and appropriate model 
loading conditions. 
4.2.1 Introduction to MSC Patran & Marc Mentat 
In this research, commercial packages from MSC Software Corporation 
(MSC Software, Santa Ana, CA), Patran, Marc Mentat and Nastran are 
employed. Patran and Mentat were used as pre and post processors 
while Marc as a non-linear solver and Nastran for topology optimisation. 
Other commercial software commonly used for structural optimisation 
include Ansys (ANSYS Inc., Canonsburg, PA), Tosca (FE-DESIGN, 
Karlsruhe, Haid-und-Neu-Strabe), Optistruct (Altair, Troy, MI) etc. 
MSC Patran and Marc Mentat enable interactive pre and post processing 
of data for solving models using the finite element method. Contact is a 
complex behaviour because of the requirement to accurately track the 
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motion of involved bodies and their interaction after contact occurs. MSC 
Marc was used to simulate deformable-deformable contact. Marc 
enables contact analyses automatically without the use of these special 
elements. Both pre and post processors (MSC Patran, Mentat) could be 
used with Marc and has the ability to process large problems in parallel 
using domain decomposition technique. 
A nonlinear analysis usually utilises incremental load (or displacement) 
steps. At the end of each increment the structure geometry changes and 
possibly the material is nonlinear or the material has yielded. Each of 
these things, geometry change or material change, may then need to be 
considered as the stiffness matrix is updated for the next increment in the 
analysis.  
An explicit or implicit incremental procedure can be implemented. An 
explicit FEM analysis updates the stiffness matrix based on geometry 
changes/material changes (at the end of each increment). Then a new 
stiffness matrix is constructed and the next increment of load or 
displacement is applied to the system. In this type of analysis the hope is 
that if the increments are small enough the results will be sufficiently 
accurate. One problem with this method is that it needs many small 
increments for accuracy and thus is computationally time consuming. On 
the other hand, if the number of increments is not sufficient, the solution 
tends to drift away from the correct solution. Additionally, this method 
does not enforce equilibrium of the internal structure forces with the 
externally applied loads.  
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An implicit FEM analysis differs from an explicit analysis with the addition 
that after each increment the analysis carries out Newton-Raphson 
iterations to enforce equilibrium of the internal structure forces with the 
externally applied loads. The implicit type of analysis tends to be more 
accurate and can take somewhat bigger incremental steps. If carried out 
correctly, the Newton-Raphson iterations have a quadratic rate of 
convergence which is very desirable. Therefore, the implicit method is 
used in the current work. 
Because of the complexity of nonlinear analyses, the solution of most 
nonlinear problems requires an incremental solution schemes and 
several iterations within each load/time step to achieve convergence. In 
MSC Marc, an adaptive multi-criteria scheme is available for contact 
analysis and was used to specify the load step procedure in this work. 
Table 4-2 describes the adaptive stepping criteria. Automatic time step 
cut back was used to adjust the increment size as necessary while 
relative displacement was specified as the criteria for the convergence 
testing. 
Table 4-2: Adaptive stepping criteria details used for contact analyses. 
Adaptive Stepping Multi-Criteria 
Initial fraction of loading time 0.01 
Minimum fraction of loading time 10-7 
Maximum fraction of loading time 0.5 
Maximum number of steps 1000 
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4.2.2 Treatment of Contact in MSC Marc 
Contact in Marc is detected by tracking nodes belonging to a contact 
body with a contact boundary condition. Contact occurs when two nodes 
are within a user set tolerance distance, which is by default equal to 5% 
of the smallest element edge length of the contacting bodies. Contact 
analysis results are mesh-dependent and finer mesh in the area of 
contact yields more accurate outcome.  
For contact problems that involve structures with large strains, two 
procedures exist in Marc, the total Lagrange and the updated Lagrange 
formulation. Since, the total Lagrange formulation is not recommended 
for material behaviour that experiences large strains and plasticity, in the 
current study, the updated Lagrange formulation was used for modelling 
stent-artery interaction. Marc automatically detects contacting bodies and 
adjusts the load step automatically to satisfy the contact condition. 
During contact analysis, a constraint minimisation problem is being 
solved where the constraint is to have “no penetration”. In Marc, 
mathematical constraints are applied to the system by using Lagrange 
multipliers for standard contact problems or by the penalty stiffness 
method for explicit dynamic problems such as impact simulation. In the 
current work, the default procedure of constraint, Lagrange multiplier, is 
used. 
4.3 Diseased Artery Selection and Analysis Steps 
As described in chapter 2, in order to create customised stents, it was 
necessary to accurately measure and map the forces acting on stents 
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exerted by complex lesions. In that pursuit, the initial step of the 
investigation was to analyse a cylinder with a set of arteries having 
different plaque types in terms of stenosis levels and materials. The 
cylinder and diseased artery contact simulates the implantation of a 
stretchable polymer-electronic balloon catheter developed by 
researchers [142,143]. These catheters aim to provide high sensitivity 
accurate information about the arterial local microenvironment such as 
temperature, material type and force exerted by lesions-which we 
assumed and gathered using contact FEA. This information is beneficial 
for the design customisation of implants, as illustrated in Figure 4-2. 
 
Figure 4-2: A complete design process for customised stents, with step 1 simulated using FEA before 
carrying out steps 2 and 3. 
In the current study, the cylinder acts as a force-extracting balloon 
catheter, similar to the mentioned concept by exploiting FE and 
measuring the exact forces applied by the arteries to tailor stent designs 
using topology optimisation. In terms of plaque morphology, based on 
clinical practice, a residual stenosis lower than 30% is considered 
acceptable [112,113], whereas a stenosis value of ≥50% is classified as 
potentially significant [157]. In addition to these geometrical features, it 
has also been reported that coronary lesions are found to be more 
eccentric or crescent-shaped [101,158]. Keeping these clinical 
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incidences in view, arteries with 30%, 50% and a median value were 
considered for the current work. Coupled with three different plaque 
stiffnesses for each, an analyses of 9 different types of diseased artery 
models was carried out. Figure 4-3 illustrates the analyses steps. 
 
Figure 4-3: Contact analysis steps. 
In MSC Marc Mentat, the motion of contacting bodies can be defined in 
the following four ways: 
 Prescribed velocity 
 Prescribed position 
 Prescribed load 
 Prescribed scaling 
Since the analysis involved arterial inflation and deflation around the 
cylinder only, face pressure was used as prescribed loading to inflate the 
artery so that the cylinder could be ‘implanted’. The detailed model setup 
is explained in the following sections. The forces resulting from cylinder-
artery contacts were used as the inputs to the stent topology optimisation 
discussed latter in the chapter. 
• Geometry creation
• FE model setup
Model Creation
• Artery-cylinder contact 
analyses for 9 plaque 
types
Contact Analysis
• Obtaining nodal 
contact normal forces 
on cylinder
Contact Load 
Extraction 
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4.4 Artery-Cylinder Model Creation 
Each stenosed artery was defined by two different parameters: stenosis 
level and plaque material type (Table 4-3). With 3 stenosis levels: 30%, 
40%, 50% and 3 plaque material types: calcified, cellular and hypocellular 
(with have clinically proven different stiffness as discussed in section 
2.10), 9 different diseased artery models and their contacting cylinder 
were created with MSC Patran. MSC Marc was employed for contact 
analysis as the non-linear solver (MSC Software, Santa Ana, CA).  
Each simulation model was composed of two bodies, a diseased artery 
and a cylinder acting as a force sensing catheter (or the generic stent in 
place of the cylinder for comparison). The cylinder used had an outer 
radius of 2.47 mm (10% greater than the artery accounting for a stent-to-
artery ratio of 1.1:1), a length of 15mm and a thickness of 0.2mm. These 
geometric values are in line with manufacturer’s recommendations and 
common stenting practice [159,160]. Each stenotic artery was modelled 
as an asymmetrical diseased vessel with a length of 20mm. The 
thickness of atherosclerotic human coronary arteries range from 0.5 to 
1.2 mm, depending on the location of the arteries on the surface of the 
heart [161]; in our study a thickness of 0.5 mm similar to a previous study 
[109], was chosen. The artery was modelled as a straight vessel with a 
localised plaque with maximum plaque tip radius of 1.56mm for 30%, 
1.22mm for 40% and 0.972mm for 50% stenosis as illustrated in Figure 
4-4. Figure 4-5 shows the generic stent used for comparison purposes. 
 
 
 
79 
 
 
Figure 4-4: Artery models with plaque types used for the analyses (XY plane cut view). 
 
Figure 4-5: Generic stent, 15mm in length, selected for comparison with optimised stents of the same 
size. 
4.5 Selection of Material Model 
The material used for the generic stent and the force extracting cylinder 
was modelled as an elasto-plastic polylactic acid (PLA) polymer blend, 
having elastic modulus, E = 3.5 GPa, yield stress σy = 60 MPa with 0.1% 
linear strain hardening and Poisson’s ratio, ν = 0.36, based on data in the 
literature [162–164]. The artery and 3 plaque types were modelled with 
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third-order non-linear hyperelastic mechanical properties suitable for an 
incompressible isotropic material based on previous studies [64,165] and 
has the form given in Eq (4.2). This has been found to adequately 
describe the non-linear stress-strain relationship of elastic arterial tissue 
[166]. 
W= C10(I1-3) + C01(I2-3) + C20(I1-3)2 + C11(I1-3)(I2-3) + C30(I1-3)3      (4.2) 
where W is the strain-energy density function of the hyperelastic material, 
I1, I2 and I3 are the strain invariants and C10, C01, C20, C11, C30  are the 
hyperelastic constants. Table 4-3 summarises the constants used for the 
hyperelastic constitutive equations to define the 4 material types. 
Table 4-3: Hyperelastic constants to describe plaque and arterial tissue [64,165]. 
Constants 
Arterial 
Tissue (kPa) 
Calcified 
Plaque (kPa) 
Cellular 
Plaque (kPa) 
Hypocellular 
Plaque (kPa) 
C10 708.416 -495.96 -802.723 165.111 
C01 -620.042 506.61 831.636 16.966 
C20 2827.33 3637.80   
C11  1193.53 1157.68 955.388 
C30  4737.25   
4.6 Meshing and Boundary Conditions 
After selecting appropriate element types, it is important to identify a 
suitable mesh size. The finer the mesh, the more accurate the result, 
although the computational time increases. Therefore, to find a suitable 
accuracy and computational time, a mesh convergence study was 
carried out. 
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There are two main methods of mesh refinement: (i) h-refinement and (ii) 
p-refinement. h mesh refinement refers to the process of increasing the 
number of elements used to model a given domain, consequently, 
reducing individual element size. In the second method, p-refinement, 
element size is unchanged but the order of the polynomials used as 
interpolation functions is increased. h-refinement method was used in the 
current study. Eight node hex, full integration elements were used to 
mesh all the atherosclerotic artery models (Figure 4-8). Mesh 
convergence studies shown in Figure 4-6 were carried out for one of the 
artery models to select an adequate mesh size. The results demonstrate 
that 41760 elements in the artery and plaque were reasonable due to 
minimal difference in the outcome due to mesh refinement as seen in 
Figure 4-6. The cylinder to be implanted for contact normal force sensing 
was modelled as a shell mesh of 6804 quad 4 elements, which would 
later act as the design domain for stent optimisation. 
 
Figure 4-6: Maximum radial displacement of plaque tip in the artery with five different meshes. 
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Figure 4-7: Graphical representation of the application of boundary conditions for the artery with 
internal pressure and axial constraints on both ends. 
The boundary conditions applied to the boundary value problem included 
pressure, displacement boundary conditions and contact (Figure 4-7). 
Both ends of the artery and cylinder were constrained axially and allowed 
to expand and contract radially. The cylinder in each case was positioned 
inside the artery with elements de-activated in the first load case as 
depicted in Figure 4-9.  
 
Figure 4-8: Hex-meshed model of 50% stenotic artery for contact analysis with cylinder (XZ cut view). 
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Figure 4-9: Relative position of cylinder and 40% stenotic artery before contact (artery sliced for 
illustration purpose). 
The vessel was then inflated by applying a pressure of 32.5 MPa for 30% 
and 40% stenosis and 65.05MPa for 50% stenosis. This pressure 
expanded the artery enough such that the 10% oversized cylinder could 
be positioned inside or “implanted.” This process was carried out in two 
load case steps; first, the cylinder elements were deactivated from the 
contact table such that the artery could expand freely. In the second step, 
cylinder elements were activated in the contact table, pressure was then 
reduced to diastole (0.013MPa) such that the artery wrapped around the 
cylinder. Contact between artery models and the cylinder was defined as 
deformable-deformable ‘touch’ contact. The size of contact tolerance can 
have significant impact on the computational cost and solution accuracy. 
For example, a small contact tolerance can lead to a high computational 
cost while a large contact tolerance can affect the solution accuracy. All 
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the artery models were solved for contact analysis separately in the same 
manner.  
For the analysis involving a generic stent, an internal pressure of 0.52 
MPa was applied to the stent initially to expand and plastically deform it 
while stenotic artery elements were deactivated. The pressure was then 
removed to allow the stent to recoil and achieve its final diameter of 5.15 
mm (10% bigger than the artery). Detailed results of the contact analyses, 
optimised stents generation and comparisons are described in chapter 6. 
4.7 Lesion-Specific Stent Topology Optimisation  
The analysis carried out initially involved 3 arbitrary scenarios of loading 
conditions, to explore and demonstrate topology variation, i.e. uniform 
loading on cylinder (to mimic 0% plaque), point crush load at the centre 
and torsion at one end. The analysis was then taken further to optimise 
stent design with respect to its stiffness for different plaque types. This 
forms the second stage in the investigation for creating lesion-specific 
stents and uses the output from the contact analyses, of different types 
of arteries with cylinder, as discussed in the preceding sections. This 
section explains the steps taken for model creation and optimisation 
setup in detail. The optimisation results and their analysis are presented 
in chapter 6. Mesh dependency and the effect minimum member size 
(MMS) control parameters for the initial loading scenarios can be found 
in Appendix D. 
As the aim was to optimise the stent design for different artery stenosis 
conditions such that the radial recoil after implantation is minimised, the 
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objective, therefore, was set to minimise the structural compliance of the 
stent or in other terms, to maximise the stiffness.  
The first stage in the design process was to extract the loading applied 
by a set of diseased arteries on a cylinder in terms of the radial contact 
normal force as described earlier. The second step was to apply the 
obtained loads to a cylindrical design domain to perform TO. In the final 
step, the optimisation results were transformed to clear, manufacturable 
design concepts and their performance was evaluated by implanting 
them in their respective stenosed artery types. The results were 
compared with a generic stent in similar arteries. The generic stent 
design was inspired by the Igaki-Tamai biodegradable stent [167], which 
is one of the few commercially produced bioresorbable stents.  
The steps taken are summarised as follows, with step (i) already 
discussed in detail in the previous section: 
(i) A contact analysis between 30%, 40% and 50% asymmetrically 
stenotic arteries by area, having three types of plaque each, with 
a cylindrical tube considered as contact force extractor or a design 
domain for stent topology optimisation. The extracted force acts 
as a loading boundary condition for step (ii). 
(ii) Topology optimisation of stents using SIMP, based on extracted 
contact normal forces on a cylinder obtained from analysis in step 
(i) for each plaque shape and material. 
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(iii) Contact analysis of the generic and optimised stents with the 
mentioned diseased vessels for performance comparison in terms 
of radial deformation. 
Figure 4-10 illustrates the steps taken to optimise and compare the stent 
designs obtained. Details of the optimisation process are explained in 
subsequent sections. 
 
Figure 4-10: Analysis steps for lesion-specific stent optimisation. 
Figure 4-11 demonstrates the proposed method of creating lesion-
specific stent using SIMP topology optimisation while highlighting the 
focus of the current work. The process begins with arterial assessment 
of a patients’ diseased artery using imaging and sensing methods to 
extract lesion compressive forces that would act if it was pushed against 
the arterial wall. A subsequent process of optimisation would follow to 
generate optimal designs for the specific conditions. 
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Figure 4-11: Proposed approach to design lesion-specific stents. 
4.7.1 Model setup and initial exploration 
In order to explore and demonstrate the variation of topology with 
changing load cases, an optimisation study of three different arbitrary 
loads was carried out. The first consisted of a uniform compressive 
pressure mimicking loading from a healthy artery with 0% plaque, then 
radial crush loading at the centre of the cylinder by two opposing point 
loads and the third with pure torsion applied to one end while keeping the 
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other fixed. For the first load case scenario, to allow both ends of the 
structure to have unconstrained nodal motion (expansion in this case) in 
the radial direction, rigid body elements (RBE3) supported by Nastran 
were used as shown in Figure 4-12 and Figure 4-13. The central node at 
one end was fixed in all six degrees of freedom. Three nodes along the 
periphery were allowed in-plane motion (UY, UZ) while the rest in the 
periphery were allowed translation in UX, UY and UZ. For the second 
load case both ends were fixed in all six degrees of freedom while radially 
inward forces were applied as depicted in Figure 4-15. In the third 
scenario, with pure torsion, RBE2 elements were used on both ends with 
one end fixed in all translations and rotation while the other central node 
at the end was subjected to torsion as shown in Figure 4-16. A uniform 
loading of 0.03 MPa was chosen for the first case based on contact 
analysis of healthy artery, whereas 7N was selected for crush and torsion 
to explore topology variation. 
 
Figure 4-12: Load case 1: Uniform inward radial load distribution representing healthy artery 
compressive pressure on cylinder (coarse mesh used for illustration purpose). 
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Figure 4-13: RBE3 elements connecting end nodes at one end of the cylinder for unconstrained 
compression. Note the three dependent nodes with free in-plane dof forming a triangle for best 
numerical conditioning while the central dependent node being fixed in all dofs (coarse mesh used for 
illustration purpose). 
 
 
Figure 4-14: Demonstration of unconstrained uniform compression due to external pressure using 
RBE3 elements. Note the Poisson effect shortening (coarse mesh used for illustration purpose). 
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Figure 4-15: Load case 2: Radial compressive force application at centre top and bottom (coarse mesh 
used for illustration purpose). 
 
 
Figure 4-16: Load case 3: Torsional load application using RBE2 elements at both ends of the cylinder 
(coarse mesh used for illustration purpose). 
Figure 4-17 illustrate the varying radial compressive force extracted from 
one of the contact analyses and applied to the design domain for 
optimisation. 
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Figure 4-17: Varying radial force on one of the stent design domains obtained from contact analysis 
with 40% stenosis with calcified plaque for TO. Central node at one end of the cylinder is allowed to 
expand/contract using RBE3 elements. Note higher forces in the middle due to peak plaque thickness. 
For the lesion-specific scenarios, the design domain for stent 
optimisation was the same as the cylinder used for contact analysis to 
extract contact forces from the arterial contact. The contact analyses 
were performed as a first step as described earlier in this chapter, thereby 
providing the loading for the optimisation problem. Figure 4-18 illustrates 
the expected load variation acting on the stent design domain resulting 
from its contact with stenotic artery. 
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Figure 4-18: Illustration of diseased artery section with cylinder implanted for force extraction 
showing expected higher compressive forces from stenotic region. 
The material used for the design domain was modelled as linear elastic 
polylactic acid (PLA), having elastic modulus E =3.5 GPa and Poisson’s 
ratio ν = 0.36, based on data in the previous literature [162]. It took the 
form of a cylindrical shell mesh of 6804 quad 4 elements.  
4.7.2 Optimisation parameters 
After performing contact analysis of the cylinder with each type of 
diseased artery, the contact normal forces on the cylinder imposed by the 
vessel in each case were applied as loads on the same sized cylindrical 
stent design domain for topology optimisation. The objective was to 
minimise the compliance 𝐶∗ of the structure (where 𝐶∗is the reciprocal 
of stiffness) or strain energy, while satisfying the constraints of volume 
removal (to meet the acceptable stent-artery coverage ratio) under 
contact loading conditions of the stenotic artery. The compliance of a 
structure is defined as 
𝐶∗ = 𝑼𝑇𝑭       5.8 
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where 𝑼 is the global displacement vector and F is the global force vector 
applied to the structure. The strain energy S of the structure is defined as 
S = 
1
2
 𝑼𝑇𝑭     5.9 
Assuming constant 𝑭, minimising compliance would mean minimising 
strain energy or the deformation 𝑼, in an elastic regime. Thereafter the 
SIMP method was applied for stent topology optimisation [77,168,169]. 
As discussed in section 2.9, this method assigns density 𝑥𝑖 to each 
element, which was the design variable of the optimisation. The SIMP 
method then minimises compliance as follows 
Objective:   𝑚𝑖𝑛 𝐶∗ = 𝑼𝑇𝑭                        5.10 
𝐶∗ = 𝑼𝑇𝑲𝑼 = ∑ 𝑢𝑖𝑘𝑖𝑢𝑖
𝑁
𝑖=1
 
                            = ∑ (𝑥𝑖)𝑝𝑢𝑖𝑘0𝑢
𝑖𝑁
𝑖=1
    
Subject to:    𝑉 = ∑ 𝑥𝑖𝑣𝑖 ≤ 𝑉0 − 𝑉
∗𝑁
𝑖=1
         5.11 
𝑭 = 𝑲𝑼 
𝑘𝑖 = (𝑥𝑖)𝑝 𝑘0 
0 < 𝑥𝑚𝑖𝑛 ≤ 𝑥
𝑖 ≤ 𝑥𝑚𝑎𝑥 < 1 
where 𝑲 is the stiffness matrix of the stent structure, 𝑢𝑖 is the 
displacement vector of the nodes, 𝑁 is the total number of elements, 𝑘0 
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and 𝑘𝑖 are the element’s initial stiffness and the stiffness matrix after 
optimisation, respectively. In the constraints, 𝑉 is the volume of the 
structure after optimisation which in this case was set to 0.3 (30%) based 
on being in the range (25%-65%) of currently available polymer stents 
[170]. 𝑉0 is the initial volume, 𝑉
∗
 the amount of material to be removed, 
𝑣𝑖 is the element volume after optimisation. 
The density design variable 𝑥𝑖 of each element has a value ranging 
between 0 (void) and 1 (solid). Closesness to 0 or 1 determined if an 
element is to be removed or kept, respectively with 𝑥𝑚𝑖𝑛 the lower bound 
of element density and 𝑥𝑚𝑎𝑥 the upper bound of element density. The 
reason for keeping a lower bound for the density instead of restricting it 
to zero is to avoid singularity of the stiffness matrix. As mentioned earlier, 
a penalty factor p is introduced to enforce the design variable to be close 
to 0-1 solution when p > 1.0. A value of p= 2 was used for this problem. 
A tolerance of convergence of 0.0001 was selected for the optimisation 
runs. Table 4-4 shows the parameters used for the optimisation. The 
Nastran input deck with all the optimisation parameters is given in 
appendix B. 
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Table 4-4: Optimisation parameters. 
Parameter Value 
Initial design variable value (XINIT) 0.5 
Lower bounds (XLB) 0.001 
Maximum design cycle (DESMAX) 250 
Penalty factor (Power) 2 
Move limit (DELXV) 0.2 
Tolerance of convergence 10-4 
Checkerboard free pattern Yes 
Symmetry constraints XY, ZX 
4.7.3 Complications in topology optimisation method 
The two main complications with topology optimisation solutions are its 
dependency on mesh size and the appearance of checkerboard pattern.  
The Checkerboard problem 
The issue of checkerboarding mainly emerges from the discretisation 
error of the FE method. This refers to the checkerboard pattern that forms 
due to the arrangement of elements with density of 0 and 1 connected 
only at corners (Figure 4-19). 
 
Figure 4-19: Checkerboard pattern in an arbitrary optimum [171]. 
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The stiffness for elements just connected by the corners is over estimated 
[172] and in SIMP the use of one variable per element and the penalising 
of intermediate densities causes checkerboard patterns to arise. There 
are a few different ways to tackle this issue, for instance, using higher 
order elements, which reduces the effect, adding filters  that smooth the 
element densities close to each other or by the introduction of a restricted 
value for the local gradient of element densities [86,173]. MSC Nastran 
provides an option for avoiding the checkerboading problem and has 
been utilised in this work. 
Mesh-dependency of solutions 
Results from SIMP TO are mesh dependent in that different structures 
are obtained when the mesh is refined without altering other parameters 
of the optimisation. Structures with finer meshes lead to different 
topologies rather than the anticipated better structural boundaries. To 
address mesh-dependency issues, there are a few techniques used such 
as perimeter control, relaxation and reduction of the admissible design 
space by adding a local or global constraint on the variation of the density 
variable, which eliminates the possibility of finer microstructure [86]. The 
filtering technique has been the most successful method to date and is 
similar to the filtering technique used for checkerboarding. It filters the 
design sensitivities and is computationally inexpensive due to not 
requiring extra constraints. Before selecting the final mesh size for the 
stent optimisation problem, several coarse meshes were analysed and a 
mesh convergence study was performed. The current mesh was selected 
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due to its compatibility with the artery contact model in-terms of mesh 
size, and computational time efficiency. 
4.7.4 Post processing 
The first phase in analysing and investigating the newly obtained 
optimised stents was to post process the resulting structures, where they 
were transformed into analysable and practical geometries. TO results 
using SIMP consists of elements with intermediate densities along with 
the solid elements in the structure. In order to proceed with this process 
the following steps were carried out: 
 Unwrapping the TO stent results 
 Filtering intermediate densities using MATLAB 
 Repairing and manual amendment using image editing software 
 Smoothing using MSC Patran’s built-in FEM smooth option 
 Wrapping the final structure back to cylindrical mesh using 
MATLAB for further investigation and comparison with a generic 
stent. 
Post-processing was also necessary to remove unwanted geometrical 
artefacts of the optimisation (such as suspended elements) in the 
optimised stent topologies that could hinder further analysis. This 
involved reducing the number of sharp corners and detached elements. 
This is important to avoid issues during the contact analysis of the 
optimised stents with the stenotic arteries. A MATLAB code was written 
to perform wrapping/unwrapping and smoothing of the resulting stent 
structures. The code is provided in appendix B. Figure 4-20 depicts 
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Patran’s FEM smooth option that was used for preliminary smoothing. 
The process was completed using MATLAB and image editing software. 
 
Figure 4-20: Patran FEM smooth option with image (b) showing smoothed elements. 
4.8 Comparison with generic stent 
The main aim of stent implantation is to keep the artery open by pushing 
the plaque against the arterial wall. Therefore a stent should have enough 
radial stiffness to deal with different types of plaques in terms of their 
shape and stiffness. In this study a set of plaque types with different size 
and stiffness were used, hence focus was on the stent performance in 
terms of radial recoil after implantation. After performing contact analysis 
of the optimised stents with their respective stenotic artery types, the final 
step of the study was to simulate a typical generic stent and compare its 
radial deformation to the topologically optimised stents.  
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For the analysis involving a generic stent, an internal pressure of 0.52 
MPa was applied to the stent initially to expand and plastically deform it 
while stenotic artery elements were deactivated. The pressure was then 
removed to allow the stent to recoil and achieve its final diameter of 5.15 
mm. The stenotic artery in each case was then inflated and deflated in 
the last load case to wrap around the stent as performed in previous 
analyses. The generic stent selected was inspired by the bioabsorbable 
Igaki-Tamai stent [167]. The material used for the generic stent was the 
same as that for the optimised stents and consisted of 6849 Quad 4 shell 
elements. The volumes of the generic and optimised stents were kept 
similar for comparison purposes. The axial motion of the stent was fixed 
and 4 nodes on both ends of the stent were constrained in a manner to 
allow radial expansion and compression. 
4.9 Summary 
This chapter explained in detail the procedures and methods used for the 
contact analyses and topology optimisation for stent design. It started 
with an introduction to the finite element method and then described the 
process of element selection and contact analysis setup. The chapter 
also explained the SIMP method with the description of the parameters 
used for lesion-specific stent optimisation for the selected stenotic 
arteries. Initial exploration of topology variation under three arbitrary 
loading scenarios was also described followed by optimisation steps for 
selected lesions. Results of the force-extracting cylinder-artery contact 
analyses and optimisation process along with comparison of generic 
stent are detailed in the results chapter.  
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The next chapter will look at the methodology used for creating the 
experimental setup for validation of the FEA. It will explain the test rig 
manufacture and stent placement in mock silicone arteries for 
comparison with FEA models. 
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5.  Experimental Validation of the 
Numerical Methods 
 
5.1 Introduction 
Computational tools are less expensive and a faster way of testing new 
devices but they lack the certainty as no model can completely emulate 
the physics of the real world. Therefore experiments are used to validate 
parts of the computational study. Furthermore, in terms of experiments, 
in vivo studies of arterial stents in animal models carry ethical and 
financial concerns whereas in vitro testing on the other hand can provide 
reasonable pre-clinical results in order to develop stent designs and 
identify any mechanical complications.  
This chapter provides details about the experimental validation of the 
computational approach used in this thesis. This was achieved by 
inflating and deflating a silicone mock artery representing a coronary 
artery in a specially designed rig along with the implantation of an 
optimised stent acquired from the preceding chapter. Two different 
scales, both self-consistent, were used in the current work. The models 
used in this chapter were scaled up 1.9 times to match the commercially 
available silicone tube. The stent and the test rig were made using 
additive manufacturing (AM) techniques. FEA simulations were 
generated by inputting the mock artery and stent geometry and material 
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properties. The radial displacements acquired from the experiments were 
measured and compared against their corresponding FEA models. 
5.2 Methods 
The goal in the experimental methodology was to visually examine the 
behaviour of stent and silicone mock artery in terms of their radial 
deformation due to internal pressure variation and stent implantation. 
Silicone NGP 60 is a biocompatible elastomer and has been previously 
used for mock artery applications. A test rig was designed for the 
experiments. Material response of silicone mock artery was also 
evaluated using simple tensile tests for FEA simulations. In order to 
deploy a stent in a mock artery, three separate experiments were 
performed as listed below: 
(a) Silicone tube inflation with given pressures 
(b) Silicone tube inflation and stent deployment followed by tube 
deflation 
(c) Stent deployment along with simulated silicone lesion 
5.3 Experimental test rig setup 
A rig was designed and developed that could adequately support the 
mock artery at both ends while allowing inflation and stent deployment 
through hollow hose connectors. One end of the rig was connected to a 
pressure line via a hose and pressure regulator while the other end 
consisted of a metal stent plunger. The rig was then clamped to a sturdy 
workbench to restrict any unwanted movements during tube inflation. A 
commercially available silicone tube with an inner diameter of 8.6 mm 
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and wall thickness of 1.6 mm was selected for the experiments. This 
would allow placement of a 10% bigger stent in terms of diameter, based 
on common stenting practice and the FEA carried out in this thesis. The 
size selected for the silicone tube matched with the size of stents that 
were ‘printable’ due to their thin struts with SLS technique, as described 
in the latter section. The mock artery was connected to the rig with the 
help of hose connections at both ends. The hose connection on the 
plunger side of the rig was created to house a stent before insertion into 
the tube. Figure 5-1 presents a schematic diagram of the test rig. 
 
Figure 5-1: Schematic diagram of the experimental test rig. 
For capturing arterial deformation images due to inflation pressure and 
stent performance evaluation, a camera was positioned close to the mock 
artery. The translucency of silicone tube enabled visualisation of the stent 
for positioning inside with the help of a specially designed plunger. Ample 
length was kept between the fixed ends of the tube to avoid any 
measurement error due to the influence of fixtures. The final test rig setup 
is illustrated in Figure 5-2, Figure 5-3 shows a close up view of stent 
delivery plunger and transparent stent housing before implantation. 
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Figure 5-2: Image showing experimental setup used for mock artery inflation and stent deployment. 
 
Figure 5-3: A close-up image of stent delivery mechanism showing transparent stent housing for 
orientation before insertion into the inflated tube. 
5.4 Additive Manufacturing of stents 
One of the stent topologies obtained, by the process described in section 
4.7, was selected for manufacture and testing. Before manufacture, it 
was necessary to transform the stent geometry to STL file format after 
smoothing the topology design, which was needed to manufacture the 
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part using AM. The STL model was then converted into slices or two-
dimensional layers using Magics® (Materialise, Leuven) software, which 
can be then used as a direct input for the machine to manufacture. 
Further requirements depend upon the individual process from CAD to 
the manufacturing process for example, the need for repairing, cutting or 
scaling of the models. Assistance in this process was provided by Mark 
Hardy. Although the stent material used for the optimisation process was 
PLA, the methodology adopted for the validation process was selective 
laser sintering (SLS) technique with nylon as the material. Nylon 12 is the 
most common material used in SLS process. Also SLS process has the 
ability to create intricate design overhangs without support material. 
Figure 5-4 shows the stent CAD model used for additive manufacturing. 
 
Figure 5-4: Stent model used for additive manufacturing and testing. 
Selective laser sintering is a powder bed fusion technique which involves 
sequentially fusing together powder particles layer by layer with a laser 
to build a part [122]. The EOS Formiga P110, which is a polymer powder 
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bed instrument that uses a 30W CO2 laser, was used for producing the 
stents. This machine has a build envelope of 200 mm x 250 mm x 330 
mm. The stent samples were successfully produced without any support 
material required. Other processes such as selective laser melting 
(SLM), material jetting, stereolithography (SLA) and fused deposition 
modelling (FDM) do require support structures if there is a certain degree 
of overhang in the design of a component. Polyamide PA2200 commonly 
known as Nylon 12 was used for stent manufacture. The material was 
also supplied by EOS in powdered form. Laser sintered PA2200 has a 
Young’s modulus of 1700+/-150N/mm2 [174], Poisson’s ratio of 0.204 
[175] and density varying between 0.90g/cm3 to 0.95g/cm3.  The stent 
model was scaled up 1.93 times to match the commercially available 
silicone tube and also to avoid manufacturing defects (Figure 5-5) due to 
very thin struts- which depends upon the layer resolution of the machine. 
Stent used for the experiments had inner radius of 9.55mm, strut 
thickness 0.38mm and a length of 29 mm (Figure 5-6). 
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Figure 5-5: Manufacturing defects: Struts at stent ends distorted due to being too thin. 
 
Figure 5-6: Scaled up optimised stent made using SLS used for the experiments. 
Using polyamide rather than PLA to make stents did not compromise the 
aim of the experimental validation since in the FEA portion for validation 
same material properties were used and it was considered appropriate 
for the proof of stent design concept. Nylon 12 and PLA have similar 
tensile properties, while human artery and the selected silicone tube both 
exhibit hyperelastic non-linear behaviour. In terms of laser sintering nylon 
12, a uniform mechanical performance was assumed throughout the 
build volume of the SLS machine. 
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5.5 Silicone tensile tests 
The material behaviour of silicone was obtained from the uniaxial tensile 
testing carried out following BS ISO 37:2017 [176] standard for 
elastomers. Silicone rubbers are hyperelastic in nature and have shown 
similar results to human vascular behaviour in tension at low stretch 
[177]. An Instron 5969 tensile test machine was used with a load cell 
capacity of 50 KN as shown in Figure 5-7. Dumb-bell specimens were 
cut according to the standard shape (Figure 5-8). 
 
Figure 5-7: Instron tensile test machine used for tensile tests. 
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Figure 5-8: Silicone dumb-bell specimen (a) dimensions and (b) samples cut from tube for tensile tests 
with die according to BS ISO 37:2017 . 
The silicone specimen data used was as follows: 
 Wall thickness- 1.6 mm 
 Gauge width- 4.0 mm 
 Grip separation rate- 500 mm/min 
The stress vs strain data obtained from 4 tensile specimen is plotted in 
Figure 5-9. Isotropic behaviour was assumed for the selected silicone 
tube. 
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Figure 5-9: Stress vs strain curves of dumb-bell samples. 
5.6 Experimental procedure 
The first experiment, consisting of a tube inflation without a stent was 
carried out with a tube sealed by closing the open end of the rig. Following 
steps were carried out: 
1. The silicone mock artery was anchored at both ends to the hose 
connections in the rig and the camera placed at approximately 30 
mm away from the centre of the vessel. 
2. An image was captured with the camera of tube with zero gauge 
pressure. 
3. Pressure was then introduced to inflate the tube and gradually 
raised to 0.15 MPa using a pressure regulator. 
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4. A second image of the tube was captured at 0.17MPa before 
deflation for image analysis. 
The steps to deploy the optimised stent were as follows: 
1. The tube was removed from the connections allow placement of 
the stent inside one of the hose connections (the stent diameter 
being 10% larger than the vessel) as shown in Figure 5-10. 
2. Image was captured of the tube without a stent zero gauge 
pressure. 
3. Pressure was then increased gradually until the 10% bigger stent 
could be inserted in to the inflated mock artery (Figure 5-11). 
4. The stent, which was placed in the tube connector, was then 
gradually inserted in to the tube with the help of a plunger and 
positioned in the middle of the tube. The stent was oriented in such 
a way that the symmetrical half was facing the camera. 
5. After stent insertion, pressure was then reduced to zero such that 
the mock artery wrapped around the stent (Figure 5-12). 
6. A second image of the final shape of the vessel was captured with 
the stent deployed for image analysis. 
 
Figure 5-10: Insertion of optimised stent in the hose connector before tube attachment. 
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Figure 5-11: Stent inserted in to the inflated artery. 
 
Figure 5-12: Stent deployment after reducing the gauge pressure to zero. 
During the experiments camera and tube movements were restricted to 
avoid any errors in measurements. Similar steps were carried out for the 
third experiment where the aim was to implant the selected stent in the 
mock artery with 40% simulated stenosis added at the centre as shown 
in Figure 5-14 and Figure 5-13. The simulated plaque was cut using a 
scalpel and measured using a Vernier calliper for dimensional accuracy. 
Figure 5-15 and Figure 5-16 depict plaque placed at the centre of the 
tube and then after stent implantation. Another method of obtaining a 
precise shape of the plaque would be to use a 3D printed trimming jig. 
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Figure 5-13: Scaled quarter model plaque with dimensions used for experimental observation. 
 
Figure 5-14: 40% simulated plaque made of the same material as the silicone mock artery, initial 
shape (a), cut to size (b). 
 
Figure 5-15: Simulated plaque added to the mock artery with the thickest part at the bottom. 
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Figure 5-16: Stent implantation in artery with 40% simulated stenosis. 
5.7 Image analysis 
X-ray micro-tomography, intra-vascular (IVUS) ultrasound and image 
processing methods have been used previously for the analysis of in-vivo 
and ex-vivo arterial strain measurements [178–183]. In the last two 
decades, with significant development of low-cost cameras and image 
processing algorithms, non-contact measurement techniques have 
become more and more common in the experimental mechanics 
community [182]. The important benefit of non-contact measurement 
techniques is that touching the sample being examined is avoided and it 
often saves cost and time. As for the current experiments it was only 
intended to capture the exterior vessel deformations, and as a 
consequence a USB camera (Microsoft LifeCam Cinema HD) which 
could capture images of size 1280 x 720 pixels, was deemed appropriate. 
The camera was aligned with the centre of the tube where a stent was 
finally to be positioned. A MATLAB code was used to process the images 
off-line, by capturing changes in the vessel external boundaries during 
the experiments. The code is given in appendix C. 
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5.8 FE Analysis 
FE analysis of a simple cylindrical tube simulating the mock silicone 
artery was carried out for validation purposes. The analysis steps were 
the same as described in section 4.4 to 4.6, apart from the fact that the 
units were consistent with the experiment. Dimensions of the tube were 
chosen to be the same as the silicone tube i.e. 8.6 mm inner diameter 
with 1.6 mm wall thickness. The model used with stent initial position is 
shown in Figure 5-17. 
 
Figure 5-17: FEA model of 40% stenotic silicone mock artery and nylon 12 stent. 
Since the analysis consisted of tube inflation and deflation, experimental 
data of only uniaxial tensile tests was deemed appropriate to be used for 
the material selection and curve fitting process in MSC Marc Mentat. 
Arteries and silicone both are non-linear hyperelastic in nature and tensile 
data has been used previously to mimic arterial behaviour [177]. 
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5.9 Summary 
This chapter described the experimental procedure carried out to validate 
the computational approach used in this thesis. This was achieved by 
measuring the variation in tube diameter due to inflation and stent 
placement using a silicone mock artery. The experimental test rig design 
and steps were discussed in detail along with the additive manufacturing 
of the optimised stent used. For FE analysis, the material input for 
silicone mock artery was evaluated by uniaxial tensile tests. Results of 
the procedures discussed are detailed in the next chapter. 
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6.  Results and Discussion 
 
 
 
6.1 Introduction 
This chapter presents the results and analysis from finite element 
analysis, optimisation and experimental work. Results arising from the 
contact analyses between the artery and force extracting cylinder are 
described which forms the basis of lesion-specific stent TO. The new TO 
stent designs were filtered, smoothed then analysed by implanting them 
in corresponding stenotic arteries and a comparison is then made against 
a generic stent design in terms of immediate post implantation recoil. 
Results from the experimental analysis of stent implantation are also 
presented that validate a portion of the FEA. Having found a suitable 
material model to represent the hyperelastic behaviour of silicone mock 
artery, one of the optimised stents was implanted with simulated stenosis 
both experimentally and numerically. Focus was kept on the arterial radial 
dimensions to analyse stent recoil. 
6.2 Investigation of initial load case scenarios 
The analysis carried out initially involved 3 different scenarios of loading 
conditions i.e. uniform loading on cylinder, point crush load at the centre 
and torsion at one end to show the effect on resulting topologies from the 
chosen arbitrary loading conditions. It is evident from TO of these load 
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cases that the geometry reacts and exhibits changes to compensate the 
applied forces. A uniform loading of 0.1MPa produces ‘stiffener rings’ 
type outcome which is consistent with conventional use of rings in 
pressure related cylindrical structures. A pair of point load simulating 
crush at the centre of the cylinder results in struts emanating from the 
centre and for torsion the design results in a helical pattern. While the 
objective function remains the same, volume fraction constraint of 0.3 
has been explored with 3 different meshes including one with varying 
minimum member size (MMS). The results presented here are from 
cylindrical mesh containing 6804 elements (mesh 1). Further refined 
meshes with 13685 (mesh 2) and 47507 elements (mesh 3) for the initial 
load case scenarios are presented in Appendix D, which demonstrate 
mesh-dependent changes in topology and strut width alteration resulting 
from change in MMS. It should also be noted that in the case of uniform 
(Figure 6-1) and pure torsional loading (Figure 6-4), the topologies do not 
vary significantly between the different mesh sizes. In the load case of 
central crush, MMS of 0.3mm, 0.4mm and 0.5mm allow a slight geometry 
change with changing strut width. Figure 6-5 shows the element density 
distribution in one of the cases (crush load) during different design cycles.  
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Figure 6-1: Mesh 1 (6804 elements) with uniform loading: (a) element density distribution, ρ, 
representing material densities between 0-1 (b) threshold 0.3 for element filtering and (c) FEM 
smoothing of the filtered elements. 
The resulting density was filtered by specifying a threshold (0.25-0.3) in 
order to obtain structures that are free from isolated or free suspended 
elements. Further smoothing option which is built-in Patran enhances the 
structure by producing a smooth transition of elements by removing 
jagged edges. Figure 6-2 illustrates the FEM smoothing results in the 
uniform loading case. 
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Figure 6-2: FEM option allowing smooth transition of elements and threshold control for enhancing 
member connectivity (a) before and (b) after applying element smoothing. 
 
Figure 6-3: Mesh 1 (6804 elements) with crush loading: (a) element density distribution, ρ, 
representing material densities between 0-1 (b) threshold 0.3 for element filtering and (c) FEM 
smoothing of the filtered elements. 
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Figure 6-4: Mesh 1 (6804 elements) with torsional loading: (a) element density distribution, ρ, 
representing material densities between 0-1 (b) threshold 0.3 for element filtering and (c) FEM 
smoothing of the filtered elements. 
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Figure 6-5: Mesh 3 (47507 elements) density distribution, ρ, with central crush loading and MMS 0.3 
during different iteration cycles. Note the minimal difference between design cycles 80 through 247. 
The results from torsion applied to one end of the cylinder were very 
similar to a previous study by Taggart et al. [184], which attempts to 
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validate topology optimised results to known theoretical solutions, an 
example of which is shown in Figure 6-6.  
 
Figure 6-6: Topology of a cylindrical structure resulting from pure torsion [184]. 
6.3 Assessment of stent-artery contact analysis 
The initial contact analyses involving the artery models with the cylinder 
were used to generate a set of contact normal forces acting radially 
inward on the cylinder for each case, to be used as the input load for the 
topology optimisation. The resultant radial force from a contact analysis 
of all 3 types of plaque materials and 3 stenosis levels is shown in Figure 
6-7, Figure 6-8 and Figure 6-9.  These results were also unwrapped from 
a cylindrical shape for illustration purposes and depict the contour plot of 
the radially inward nodal forces on the cylinder. It can be noted that 
highest load is acting in the top-left edge (-ve Z-axis) due to plaque peak 
thickness. 
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Figure 6-7:Contour plot showing radially inward nodal load (N) variation on the design space for stent 
topology optimisation based on cylinder-artery contact with 30% calcified (a) hypocellular (b) and 
cellular plaques (c) along with unwrapped versions from cylindrical shape for illustration purpose. 
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Figure 6-8: Contour plot showing radially inward nodal load (N) variation on the design space for stent 
topology optimisation based on cylinder-artery contact with 40% calcified (a) hypocellular (b) and 
cellular plaques (c) along with unwrapped versions from cylindrical shape for illustration purpose. 
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Figure 6-9:Contour plot showing radially inward nodal load (N) variation on the design space for stent 
topology optimisation based on cylinder-artery contact with 50% calcified (a) hypocellular (b) and 
cellular plaques (c) along with unwrapped versions from cylindrical shape for illustration purpose. 
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It is evident from these contact analyses of different plaques with the 
cylinder that calcified plaque exerts the highest peak compressive force 
followed by hypocellular plaque with the lowest peak force from cellular 
plaque. This is in agreement with their stiffness level. These peak values 
are summarised in the table below. 
Table 6-1: Peak compressive force exerted by stenotic arteries on cylinder after deflation to diastole. 
 Peak Compressive Force (N) 
Stenosis (%) Calcified Cellular Hypocellular 
30 0.057 0.034 0.044 
40 0.097 0.033 0.043 
50 0.166 0.050 0.052 
6.4 Lesion-specific stent topology optimisation results 
Topology optimisation using the force distribution from the contact 
analysis was used to generate the optimal material distribution of material 
for the 9 different plaque loading conditions. Figure 6-10, Figure 6-11 and 
Figure 6-12 show the optimisation solution convergence of compliance 
against the number of iterations of stents under stenosis load of 30% 
(6.67, 2.11 and 2.20 Nmm), 40% (25.40, 7.54 and 4.76 Nmm) and 50% 
(66.10, 8.75 and 9.35 Nmm) for calcified (a), cellular (b) and hypocellular 
(c) plaque scenarios respectively. Hard convergence criteria was 
achieved (compares the results of this most recent finite element analysis 
with those from the previous design cycle) based on convergence 
tolerance 0.0001. 
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Figure 6-10: Stent topology optimisation convergence plots: compliance (Nmm) with respect to design 
iterations for 30% stenosis for: (a) calcified, (b) cellular and (c) hypocellular plaque types respectively. 
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Figure 6-11: Stent topology optimisation convergence plots: compliance (Nmm) with respect to design 
iterations for 40% stenosis for: (a) calcified, (b) cellular and (c) hypocellular plaque types respectively. 
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Figure 6-12: Stent topology optimisation convergence plots: compliance (Nmm) with respect to design 
iterations for 50% stenosis for: (a) calcified, (b) cellular and (c) hypocellular plaque types respectively. 
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Figure 6-13 shows the normalised material density distribution, from TO 
with a 0.3 volume fraction constraint. The resulting amount of material in 
each optimised stent was similar to the generic stent (varying less than 
5%). The results were unwrapped using MATLAB to form a flat 2D plot 
for illustration purposes. It can be seen that there is a higher material 
concentration in the central part of the stent, as a consequence of the 
plaque induced higher forces here as previously shown in Figure 6-14, 
especially in the centre of the lower half of each stent where it comes into 
contact with the thickest part of the plaque in each case. 
 
Figure 6-13: Stent topology optimisation density distribution results for (a-c) 30%, (d-f) 40% and (g-i) 
50% stenosis for calcified, cellular and hypocellular plaque types respectively (results of axial-stent-
half unwrapped from cylindrical shape for illustration purposes). 
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MATLAB and image editing software were used to unwrap, construct and 
smooth the optimisation geometry in order to transform it into an 
analysable stent structure, as illustrated in Figure 6-14. This modification 
led to an additional 5-10% volume increase of the stent but the overall 
volume remained in the range of current stents in practice. 
 
Figure 6-14: Stent topologies for (a-c) 30%, (d-f) 40% and (g-i) 50% for calcified, cellular and 
hypocellular plaque types respectively, (results unwrapped from cylindrical shape for illustration 
purpose). 
The smoothed optimised stent results were then wrapped to form 
cylindrical shapes and solved for contact analysis with their respective 
arteries in the same manner as the contact FEA with the force extracting 
cylinder. The final lumen radial deformation of 20 equidistant points in 
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each of the diseased arteries along the thickest part of the plaque were 
recorded to provide a comparative measure of the ability of the stent to 
maintain an arterial opening. 
6.5 Assessment of radial displacement 
For comparison, the first step was to evaluate recoil of a generic stent in 
stenotic arteries with different plaque materials for 30, 40 and 50% 
stenosis levels.  Plaque peak thickness in the 30% stenosis protruding 
inside the artery had a minimum unstented radius 1.56 mm. After 
implantation of optimised stents, this increased to 2.43 mm, 2.54 mm and 
2.54 mm, representing 2%, 0.5% and 1% residual stenosis, for calcified, 
cellular and hypocellular plaques respectively with the corresponding 
optimised stent. This difference in the narrowest lumen radius is shown 
in Figure 6-15 as 0.87mm, 0.98mm and 0.98mm. In the same scenario, 
lumen position values after generic stent implantation were 2.17 mm, 
2.29 mm and 2.24 mm for calcified, cellular and hypocellular plaques 
respectively (Figure 6-18). In the 40% stenotic artery, the unstented 
minimum position from central axis was, as expected, even less than with 
the 30% plaque, at 1.22mm. After stenting with the optimised designs, 
lumen gain was achieved, with the minimum radius increasing to 2.24 
mm, 2.51 mm and 2.34 mm representing 2%, 0.5% and 2% residual 
stenosis, for calcified, cellular and hypocellular plaques respectively, with 
the corresponding optimised stent. This amounted to a difference of 
1.02mm, 1.29mm and 1.12mm as illustrated in Figure 6-16. Results in 
the same environment with a generic stent were 1.68 mm, 2.13 mm and 
2.0 mm for calcified, cellular and hypocellular plaques respectively 
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(Figure 6-19). Similarly for 50% artery stenosis, plaque peak thickness 
had an unstented position of 0.972 mm in the Z direction. After stenting 
this increased to 2.06 mm, 2.49 mm and 2.50 mm, representing 6%, 4% 
and 3% residual stenosis, for calcified, cellular and hypocellular 
respectively, with the corresponding optimised stent. This amounted to a 
difference of 1.08mm, 1.51mm and 1.52mm as illustrated in Figure 6-17. 
In similar conditions, lumen positions with a generic stent were 1.54 mm, 
1.97 mm and 1.78 mm for calcified, cellular and hypocellular plaques 
respectively (Figure 6-20). Increase in the lumen diameter post-stenting 
with generic and optimised designs are summarised in Table 6-2, 
measured at the plaque peak position. 
Table 6-2: Post-stenting lumen gain in the generic and optimised designs due to peak plaque radius 
change. 
Stenosis 
(%) 
Post-stenting lumen radius gain (mm) 
Calcified Cellular Hypocellular 
Generic Optimised Generic Optimised Generic Optimised 
30 0.61 0.87 0.73 0.98 0.68 0.98 
40 0.46 1.02 0.91 1.29 0.78 1.12 
50 0.56 1.08 0.99 1.51 0.80 1.52 
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Figure 6-15: Deformation plot (mm) showing contact of optimised stents with their respective stenotic 
arteries having 30% calcified (a) cellular (b) and hypocellular plaques (c). 
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Figure 6-16: Deformation plot (mm) showing contact of optimised stents with their respective stenotic 
arteries having 40% calcified (a) cellular (b) and hypocellular plaques (c). 
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Figure 6-17: Deformation plot (mm) showing contact of optimised stents with their respective stenotic 
arteries having 50% calcified (a) cellular (b) and hypocellular plaques (c). 
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Figure 6-18: Deformation plot (mm) showing contact of a generic stent with stenotic arteries having 
30% calcified (a) cellular (b) and hypocellular plaques (c). 
 
 
139 
 
 
Figure 6-19: Deformation plot (mm) showing contact of generic stent with stenotic arteries having 
40% calcified (a) cellular (b) and hypocellular plaques (c). 
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Figure 6-20: Deformation plot (mm) showing contact of generic stent with stenotic arteries having 
50% calcified (a) cellular (b) and hypocellular plaques (c). 
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For the optimisation study carried out, the issue of structural integrity was 
not explored in detail as the aim of this work was to show geometry 
dependency and its relative performance in a given loading scenario. 
However, structural integrity of mechanical components is crucial in 
service and can be measured using maximum stresses. TO normally 
offers the first phase of a design optimisation process. The next phase 
would commonly consist of shape or size optimisation to ensure the 
structural integrity of the optimal designs and its manufacturability. For 
demonstrating the usefulness of the new designs, maximum principal 
and shear stress results of the generic and optimised designs of 30% 
stenosis in calcified, cellular and hypocellular plaques are presented in 
Figure 6-21 to Figure 6-24. As expected these stress contours reveal higher 
stresses in the central region on stents implanted in calcified plaques 
compared to hypocellular and cellular plaques. Furthermore, peak 
maximum stress value in generic stents (beyond intended plastic 
deformation to strain harden) was found to be 65.5 MPa compared to 
peak value in the optimsed design of 45.0 MPa, which thus satisfies the 
structural integrity as the designs were not intended for expansion/plastic 
deformation. As the maximum principal results represent the 
compressive hoop stress exerted by the lesion, they are shown as a 
negative value. Maximum shear stress on the other hand was also higher 
in generic stent in all three plaque cases i.e. 32.9 MPa compared to 
optimsed designs where they peaked at 22.5 MPa. It is also expected 
that modification of these optimised stent structures could further lower 
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the peak stresses by automated size or shape optimisation or manually 
adjusting a parametric CAD geometry. 
 
Figure 6-21: Stress plots (MPa) for calcified 30% (a-c), cellular (d-f) and hypocellular (g-i) representing 
compressive principal stress. 
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Figure 6-22: Stress plots (MPa) for calcified 30% (a),  cellular (b) and hypocellular (c) representing 
maximum shear stress. 
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Figure 6-23: Stress plots (MPa) for optimised stents placed in arteries with calcified 30% (a),  cellular 
(b) and hypocellular (c) plaques representing compressive principal stress. 
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Figure 6-24: Stress plots (MPa) for optimised stents placed in arteries with calcified 30% (a),  cellular 
(b) and hypocellular (c) plaques representing maximum principal shear stress. 
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Figure 6-25: Final lumen radial deformation with a generic stent (a-c) and optimised stents (d-f) for 30, 
40 and 50% stenotic arteries respectively with different plaque types based on 11 equally distant 
points longitudinally along thickest part of plaque, relative to central axis (one half of the stenotic 
artery deformations illustrated). 
Analysis of the generic stent studied shows that severe calcification could 
lead to immediate lumen gain after the implantation of the stent as 
illustrated in Figure 6-20. The generic stent deployed in the calcified 30%, 
40% and 50% diseased vessel, recoiled significantly more than the 
optimised stents in the central region leading to 10%, 29% and 35% 
residual stenosis respectively (Figure 6-25 & Figure 6-26). This was in 
agreement with a previous study [111]. 
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Figure 6-26: Post implantation stenosis levels in the remodelled artery due to optimised and generic 
stents recoil. 
In other words, in spite of having similar volume of material, the stent 
showed less efficacy in supporting the disease and the displacement 
could not meet the limits of standard stenting effectiveness of 30% or 
lower allowable immediate post-implantation residual stenosis [112,113]. 
6.6 Experimental validation results 
Three separate experiments were performed to extract the mock silicone 
artery’s external diameter in XZ view with the help of a digital camera. In 
the first experiment, which involved only inflation and deflation of the 
artery with air pressure, the initial diameter was 11.8 mm at zero gauge 
pressure. With the application of 0.15 MPa, it increased to 13.9 mm as 
shown in Figure 6-27. This pressure was enough to implant a 10% bigger 
size stent in the mock artery, which was the second experiment (Figure 
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6-28). Several trials were carried out with pressure variations to get 
consistent results against a black background. 
 
Figure 6-27: Image of mock silicone artery (XZ view) before inflation (a) and superimposed image of 
after inflation showing boundaries using MATLAB. 
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Figure 6-28: Mock silicone artery (XZ view) before (a) and after (b) stent implantation. Both images 
superimposed in MATLAB showing external tube boundaries (c). 
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The third experiment consisted of placement of a 40% stenosis inducing 
plaque at the centre of the tube before implantation of the additively 
manufactured nylon 12 optimised stent (Figure 6-29). 
 
Figure 6-29: Mock silicone artery (XZ view) with 40% stenosis before (a) and after (b) stent 
implantation. Both images superimposed in MATLAB showing external tube boundaries (c). 
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It is demonstrated that the optimised stent owing to its greater material 
distribution at the centre exhibits an ability to withstand the higher 
compressive forces from plaque, hence keeping the lumen wider. The 
images clearly show a bulge in the exterior dimensions (XZ), which is an 
indication of plaque being pushed by the stent. The uniaxial tensile 
testing of silicone dumbbell samples stress vs strain data followed 
Mooney-Rivlin hyperelastic material model closely in MSC Marc Mentat 
in the curve fitting process to the curves of uniaxial tensile, biaxial and 
planar shear modes, especially at low strain, as illustrated in Figure 6-30. 
 
Figure 6-30: Experimental uniaxial tensile data curve fit of silicone NGP60 with Neo-Hookean model in 
MSC Marc Mentat. 
Subsequent FEA of optimised stent implantation in mock 40% stenotic 
silicone artery also demonstrated a reasonable correlation with the 
experimental analysis. The radial position of artery exterior from XZ view, 
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which showed the plaques thickest part, was evaluated and compared 
with the arterial boundary extracted from experiment using MATLAB 
image analysis. The external diameter of the tube at mid length before 
pressure inflation was 11.8 mm, which after stent implantation increased 
to 13.9 mm as depicted in Figure 6-31, Figure 6-32 and Figure 6-33. The 
corresponding final diameter of the experimental analysis was found to 
be 14.9mm. 
 
 
Figure 6-31: FEA model of stenotic mock silicone artery with stent: Deformation plot showing radial 
displacement (mm). 
 
Figure 6-32: Deformation plot illustrating radial displacement (mm) in mock artery cross-section with 
stent implanted. 
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Figure 6-33: Radial displacement plot of arterial external boundary (XZ view) with 40% stenosis before 
and after stent implantation in FEA. 
Displacements gathered from the experiment involving stenting of the 
40% stenotic artery were then compared with FEA analysis results. 21 
equidistant points were selected on the boundary of axially symmetrical 
half of the model for diameter calculation. The change in pre and post 
stenting diameters was calculated for both, the simulation and the 
experiment, and is illustrated in Figure 6-34. The root mean squared 
difference between them was found to be 0.626 mm which accounts for 
a 4% error. 
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Figure 6-34: Diameter variation resulting from pre and post optimised stent placement in FEA and 
experimental models (plot showing axial half). 
These results reveal the ability of the proposed design method, utilising 
contact FEA and topology optimisation, to generate optimised stents able 
to restore the lumen area for given plaque types to an acceptable level, 
i.e. resulting lower recoil than 30% residual stenosis, whilst retaining the 
beneficial features of the standard stent, such as lower stent volume. It 
could be noted that the calcified lesion (Figure 6-25 & Figure 6-26), owing 
to its greater stiffness, led to slightly lower stented lumen area compared 
to the other plaque types in all types of stenosis, as expected, however, 
with the optimised stent, performance post stenting is still acceptable.  
The results also show that a 50% stenosis lead to an increased post 
stenting radius of 2.50 mm compared to 2.34 mm for a hypocellular 40 
percent stenosis (Figure 6-25). This slight variation in post-implantation 
reduction in radius was expected and is believed to be attributed to the 
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change in structure resulting from post-processing of raw stent 
topologies. The variation was deemed acceptable as the post-
implantation stenosis levels were well below 30%. 
The results obtained from the topology optimisation give a concept 
design and demonstrate that stents could be tailored according to the 
accurate loading conditions in specific-plaques geometries as opposed 
to the current ‘off-the-shelf’ stenting practice. Post-processing of the stent 
designs obtained from the topology optimisation (Figure 6-13) is an 
important step as changing the geometry could lead to altered stiffness, 
if not performed carefully. 
In terms of implantability, it is also important to note that the designs 
derived from topology optimisation (Figure 6-14) are anisotropic in nature 
and are only optimised if the stents can be placed such that the regions 
with higher strut densities are placed in the artery at a specific angle with 
respect to the lesion. Another important clinical implication of the current 
work, when combined with an appropriate expanding mechanism (e.g. 
ratchet expansion), is that the issues arising from overexpansion of stents 
could be eliminated which has been found to be one of the reasons for 
ISR [32]. Another beneficial aspect of the new geometries is that the stent 
design criteria of withstanding 400 million fatigue cycles required by FDA 
[114] will not be needed due to their bioresorbable nature as some 
studies suggest that the presence of stents benefits the affected site only 
for a number of weeks [49].  
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The method proposed in chapter 4 for arterial load assessment using 
FEA could be realised by the use of a multi-functional balloon catheter 
[143] that can potentially capture patient-specific lesion compressive 
forces. This data will also represent the level and severity of the plaque 
condition. These loads could then be translated to FEA for stent topology 
optimisation.  
The experimental method described, provided information about the 
varying radial stiffness of the stent in a simulated mock stenotic artery 
which was able to maintain lumen patency. These results exhibited a 
reasonable agreement with the FE model. This highlights that while 
computational tools are helpful in developing new stent designs, 
experimental prototypes are necessary to physically validate those 
concepts in reality and formulate hypothesis for further in vivo study. 
6.7 Summary 
This chapter presented the results of cylinder-artery contact analysis and 
the generation of optimised stent designs for specific lesions with varying 
plaque size and materials. The obtained designs were then filtered before 
simulating them in their respective stenotic arteries and comparison 
against a generic stent. It was evident from the results that the new 
customised designs showed lower recoil in varying plaque conditions. 
This chapter also described the results acquired from experimental 
validation of the FEA approach. One of the optimised stents was 
additively manufactured and implanted in a mock silicone artery with 40% 
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stenosis. The results achieved from FEA analysis showed a close 
correlation with the corresponding experiment. 
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7.  Conclusions & future work  
 
7.1 Conclusions 
A topology optimisation method has been applied to obtain optimal stent 
geometries for a set of specific lesion sizes and types. Nine different 
possible scenarios were analysed with varying plaque morphology i.e. 
30%, 40%, 50% and composition i.e. calcified, cellular and hypocelluar. 
In each of the scenario, compressive contact pressure was evaluated and 
then used to optimise stents in order to minimise recoil for the 
corresponding case.  
After transforming the TO results to clear design concepts, it has been 
demonstrated that such designs are able to maintain lumen area to a 
greater degree than a generic stent. Through mechanical design the stent 
recoil was reduced, even under conditions of significant stenosis and 
strong variations in the material solid rheology. 
The designs achieved look unconventional but they make engineering 
sense. They are also anisotropic in nature hence they will require 
implantation in the artery at a specific angle with respect to the lesion. 
That could be achieved through an approach similar to that of Hong et al. 
[185], for example, incorporating multiple radio-opaque markers in to the 
new designs possibly on proximal and distal ends. Hong el al. used this 
technique (in vitro) to avoid side branch jailing in bifurcation lesions 
whereas in designs generated in the current study, it could be used to 
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manipulate angular positioning with respect to the lesion. In regard to 
material for markers, gold or bioabsorbable radio-opaque materials (e.g. 
impregnation with iodine as used in REVA stent [170,186]) could be 
considered. 
Balloon pre and post-dilation is commonly performed in procedures to 
modify an uneven plaque distribution to create a more uniform lesion to 
be stented [187]. Due to the customised nature of the new designs, the 
proposed method also has an additional potential benefit to eliminate the 
need for this additional procedure. Direct stenting with the optimised 
designs will also make the procedures faster, easier, economical and 
reduce the cost and procedural risks associated with the pre and post-
dilation. The generic stent selected for comparison purposes represents 
the vast majority of stents with ‘links’ and ‘rings’ design having almost 
constant radial stiffness along its length. Development of the new designs 
illustrate that a stent could be tailored having variable radial stiffness, 
using topology optimisation, in contrast to generic stents. 
The findings can be summarised as follows: 
1. The contact analysis of the different plaque scenarios revealed 
that peak contact normal force on ‘implanted’ force-extraction 
cylinders in calcified lesions was the highest as expected due to 
higher stiffness of the plaque i.e. 1.3 and 1.6 times higher than in 
hypocellular and cellular plaques respectively in 30% stenosis. 
Similarly it was 2.2 and 2.9 times higher in 40% stenosis while in 
50%, it was 3.1 and 3.2 times higher. 
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2. The new topology optimised stent designs were able to achieve 
higher lumen gain and lower residual stenosis compared to the 
generic stent. In artery with 30% stenosis, the residual value was 
reduced to 2%, 1% and 0.5% in calcified, hypocellular and cellular 
lesions respectively. Similarly, in the 40% scenario it was reduced 
to 2%, 2% and 0.5% while in the 50% case, 6%, 3% and 4% 
residual area stenosis levels were achieved. For the generic stent 
on the other hand, residual stenosis values for 30%, 40% and 50% 
occlusions were 10%, 29% and 35% respectively showing higher 
recoil. 
3. Each topology optimised stent design showed higher density of 
material distribution and strut concentration in areas where plaque 
was thickest, which is a result of higher compressive stress paths 
generated by lesion contact and hence contributed to lower recoil 
in each case. This allows design adaptation of different lesion 
types, for instance, the resulting stents are stiffer in the central 
region to push the plaque and less stiff at the ends-hence exerting 
lower force on the healthy part of the artery. 
4. The experimental validation of the computational approach with  
additively manufactured nylon 12 optimised stent implanted in 
40% simulated stenotic silicone mock artery showed close 
correlation between its corresponding FEA analysis of the same 
scale, which demonstrates a proof of concept for the current 
methodology. 
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7.2 Limitations and Future Work 
Topology optimisation results are normally mesh-dependent and 
therefore could be further investigated by employing different methods to 
refine the desired solution. One such recently developed method [152] is 
the use of extended finite element method (X-FEM), which is an 
evolutionary optimisation method and allows to obtain smooth and clearly 
defined structural boundaries and would potentially reduce the need to 
modify the TO results to obtain a manufacturable design. Another 
emerging computational mechanics approach known as isogeometric 
analysis (IGA), has been developed relatively recently and is gaining 
further attention. This technique, the key concept of which was outlined 
by Hughes et al. [188], can be considered as an alternate to standard FE 
analysis and offers a possibility of integrating analysis and CAD 
(Computer Aided Design). It utilises the predominant CAD technology 
NURBS (Non-Uniform Rational B-Spline), which is used to represent 
complex geometries, not only as geometry discretisation but also as a 
discretisation tool for analysis [189]. This can reduce the time it takes to 
design and analyse significantly leading to greater efficiency while 
allowing exact CAD depiction and simplified mesh-refinement. In stent 
design context, this technique could provide effective representation of 
complex lesion shapes and potentially efficient computational cost. 
The current work does not consider stent crimping and expansion 
process in the design approach and is focused on early-stage topology 
optimisation to achieve geometries at a conceptual stage. A complete, 
but challenging solution is to use a topology optimisation method to 
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create a compliant mechanism [190] and simulate implantation. 
However, one is not always dependent on plastic deformation to fix a 
stent, for example, another one potential route is to incorporate a ratchet-
like mechanism to the designs similar to the REVA stent and a recoil 
prevention device [170,186,191], which upon balloon expansion has 
struts that slide and lock without plastic deformation of the stent. In the 
future, a more complete study will involve the examination of curved and 
bifurcating systems, as well as the importance of advanced material 
models including anisotropic, plastic, failure modes [192,193] and stent 
fatigue. Further studies should also consider other materials such as 
stronger bioresorbable polymers and biocompatible super-elastic alloys 
such as nitinol. 
This approach to design of stents will likely realise complex topologies 
that will be difficult to manufacture with traditional techniques. Whilst 
these could be manufactured using, for example, laser cutting methods 
common for stent production, a technology for the future is additive 
manufacturing. This technology could also potentially be utilised to 
custom design bioresorbable polymer scaffolds, as suggested, with micro 
mechanisms for expansion- studies in which have been carried out [194–
196]. That could be achieved by determining full 3D patient specific 
arterial geometries and properties prior to stenting to optimise the 
outcome of stenting procedures. Production and modification of metallic 
stents has already been demonstrated and printable polymeric 
biomaterials for drug release and implants are becoming more widely 
available [197–204]. Medical applications for additive manufacturing and 
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3D printing are rapidly rising and could potentially revolutionise 
healthcare with many benefits such as customisation, cost-effectiveness 
and increased productivity [205]. Unlike the current stents, which mostly 
have repeating cellular strut structure, the new designs will likely be cost-
effective in lesions with significant asymmetric plaque morphology due to 
their varying radial stiffness properties. In addition to that, customisation 
of designs have the potential to offer tailored solutions in conjunction with 
improved quality of life as shown in other implants for example, cranial 
reconstruction [206]. However it should be noted that in spite of the 
exciting applications there still remain notable regulatory challenges. 
The workflow presented here has potential benefit not only for the 
personalised treatment of CVD; the scalability and freedom of design 
based AM offers a benefit for other intravascular applications. The 
combination of design, additive manufacturing and identification of 
patient specific arterial geometries and properties offers considerable 
patient benefit. 
The custom stent test rig designed and developed in this work using 
additive manufacturing and 3D printing techniques has the potential to 
provide a base for further investigation of experimentally analysing and 
testing numerous stent designs and plaque conditions in order to 
customise the treatment. However, it does not provide three dimensional 
local strain. The set up if used in conjunction with optical surface strain 
measurement system, as utilised by Steinert et al. [181], could provide 
more information about surface variation in complex asymmetrical 
lesions.  
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 Stent studies focus Conclusion 
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Dogboning & Balloon Expansion 
studies 
Increased strut width at distal ends and 
eliminate dogboning 
FEA 
Wang et al., 
2004 [61] 
Yes 
Expansion & Recoil 
The ideal stent posseses a low profile, 
uniform expansion, good flexibility to 
navigate tortous vessesl, adequate 
radiopacity, low recoil, sufficient radial 
strength, a low metal surface area and 
high scaffolding ability. 
Clinical 
McClean et 
al., 2002 
[126] 
No 
Expansion & Dogboning study 
Asymmetric design decreases dogboning 
from 27% to less than 10%` 
FEA 
De Beule et 
al., 2008 
[70] 
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Dogboning, Foreshortening & 
Contact Study 
Vascular Injury is caused by dogboning, 
foreshortening and excessive balloon 
contact 
Clinical 
Garasic et 
al., 2000 
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Review on stent expansion, 
dogboning and strut distribution 
Forces of expansion should be distributed 
evenly to facilitate uniform expansion 
Clinical 
Gunn et al., 
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Dogboning results  investigation 
Non-uniform expansion increases 
vascular injury 
Clinical 
 
Farb et al., 
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Dogboning and recoil study 
A stent with a low metal-to-artery surface 
ratio has a higher radial and longitudinal 
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Migliavacca 
et al., 2002 
[60] 
Yes 
 
 
184 
 
Shape Optimisation for 
minimum dogboning, recoil & 
radial loss 
Changes in wave lengths at the distal 
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Stent geometry 
parameterization 
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Strut thickness study Thicker struts cause more arterial injury Clinical 
Rittersma et 
al., 2004 
[35] 
No 
Strut thickness Strut thickness confirmed vessel injury Clinical 
Hoffman et 
al., 2001 
[211] 
No 
Comparison of two stents with 
different struts per cross-section 
Less struts per cross-section causes more 
arterial injury 
Clinical 
Garasic et 
al., 2000 
[207] 
No 
Topology optimisation of stent 
struts to create drug reservoirs 
Effective topology with stiffer and less 
volume struts developed for same amount 
of drug as commercially available initial 
design 
FEA 
Wu et al., 
2008 [109] 
 
Yes 
 
Parametric model of colonic 
stents 
Variable stent diameters achieved for 
colonic stent in order to be obstruction-
specific. 
FEA 
Puertolas et 
al., 2017 
[97] 
Yes 
 
Parametric stent design for 
coronary arteries 
Stent strut size optimisation for lower von-
mises stresses and better fatigue life. 
FEA 
Amirjani et 
al., 2014 
[98] 
Yes. 
 Size optimisation of stent design 
Study achieved better fatigue life by 
employing kriging surrogate model. 
FEA 
Li et al., 
2017 [96] 
Yes 
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Appendix B 
 
Code for unwrapping Nastran stent 
model and stent topology 
optimisation input deck 
 
This appendix contains the code written in MATLAB for unwrapping, 
smoothing and wrapping 3D cylindrical stent TO results from MSC 
Nastran model files for smoothing and illustration purposes. Model input 
deck is also presented at the end for Nastran optimisation. 
%% Tranformation to the points 
fid2 = fopen([file_path 'input.txt']); 
node_inp = textscan(fid2, '%s', 'delimiter', '\n'); 
fclose(fid2); 
 
no_nodes_in_cyl_cut = 84; 
node_data = node_inp{1}; 
  
x = zeros(no_nodes_in_cyl_cut,1); 
y = x; 
z = zeros(size(node_data, 1), 1); 
node_ids = z; 
  
for(i=1:no_nodes_in_cyl_cut) 
    y(i) = str2num(node_data{i}(33:40)); 
    x(i) = str2num(node_data{i}(41:end)); 
end 
  
for i=1:size(node_data, 1) 
    node_ids(i) = str2num(node_data{i}(9:17)); 
    z(i) = str2num(node_data{i}(25:32)); 
end 
  
  
R = 2.475; 
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theta = abs(atan(x./y)); 
  
only_y_negative = false(size(theta)); 
only_x_negative = only_y_negative; 
x_y_negative = only_y_negative; 
  
only_y_negative(y<0) = 1; only_y_negative(x<0) = 0; 
only_x_negative(x<0) = 1; only_x_negative(y<0) = 0; 
x_y_negative(y<0) = 1;  x_y_negative(x>0) = 0; 
  
case_1 = find(only_y_negative==1); 
case_2 = find(only_x_negative==1); 
case_3 = find(x_y_negative==1); 
  
theta(case_1) = pi-theta(case_1); 
theta(case_2) = 2*pi-theta(case_2); 
theta(case_3) = pi+theta(case_3); 
  
% theta(end+1) = theta(1)+2*pi; 
x_new = R*(theta); 
  
times = floor(size(node_data,1)/no_nodes_in_cyl_cut); 
node_zyx = zeros(size(node_data,1),4); 
  
for(i=1:times) 
    node_zyx(no_nodes_in_cyl_cut*(i-
1)+1:no_nodes_in_cyl_cut*i,4) = x_new; 
end 
  
node_zyx(:,2) = z; 
node_zyx(:,1) = node_ids; 
node_start_max_old = max(node_ids); 
  
  
add_node_zyx = zeros(times,4); 
add_node_zyx(1:times,1) = 
[node_start_max_old+1:node_start_max_old+times]; 
add_node_zyx(1:times,2) = 
node_zyx(1:no_nodes_in_cyl_cut:no_nodes_in_cyl_cut*times,
2); 
add_node_zyx(1:times,3) = 
node_zyx(1:no_nodes_in_cyl_cut:no_nodes_in_cyl_cut*times,
3); 
add_node_zyx(1:times,4) = 
node_zyx(1:no_nodes_in_cyl_cut:no_nodes_in_cyl_cut*times,
4)+2*pi*R; 
  
  
replace_nodes = zeros(times,3); 
replace_nodes(:,1) = 
node_zyx(1:no_nodes_in_cyl_cut:no_nodes_in_cyl_cut*times,
1); 
replace_nodes(:,2) = 
node_zyx(no_nodes_in_cyl_cut:no_nodes_in_cyl_cut:no_nodes
_in_cyl_cut*times,1); 
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replace_nodes(:,3) = 
[node_start_max_old+1:node_start_max_old+times]; 
  
final_node_zyx = [node_zyx; add_node_zyx]; 
  
  
%% element arrangement addressing 
fid2 = fopen([file_path 'faces.txt']); 
element_inp = textscan(fid2, '%s', 'delimiter', '\n'); 
fclose(fid2); 
  
faces = zeros(size(element_inp{1}, 1), 4); 
for i = 1:size(element_inp{1}, 1) 
    line = element_inp{1}{i}; 
    faces(i, :) = [str2num(line(25:32)), 
str2num(line(33:40)), str2num(line(41:48)), 
str2num(line(49:end))]; 
end 
  
faces_old = faces; 
for(j = 1:size(element_inp{1}, 1)/no_nodes_in_cyl_cut) 
     
    temp_vec_1 = faces(no_nodes_in_cyl_cut*j,:); 
    ind = find(replace_nodes(:,2)'==temp_vec_1(1)); 
    ind2 = find(temp_vec_1(:)==replace_nodes(ind,1)); 
    ind3 = find(temp_vec_1(:)==replace_nodes(ind+1,1)); 
           
    faces(no_nodes_in_cyl_cut*j,ind2) = 
replace_nodes(ind,3); 
        faces(no_nodes_in_cyl_cut*j,ind3) = 
replace_nodes(ind+1,3); 
end 
  
  
%% read in density results for each element and plot as 
patches 
fid2 = fopen([file_path 
'30_calcified_dof_zero_removed.des']); 
dens_inp = textscan(fid2, '%s', 'delimiter', 
'\n','headerlines', 4); 
fclose(fid2); 
  
ids = dens_inp{1}(1:2:end); 
dens = str2num(cell2mat((dens_inp{1}(2:2:end)))); 
ids2 = zeros(size(ids, 1),1); 
for i = 1:size(ids, 1) 
ids2(i) = str2num(ids{i}(1:8)); 
end 
  
% code for addition of empty rows so that consistent row 
numbers for vertices for patch 
vertices = zeros(max(final_node_zyx(:, 1)), 4); 
for i = 1:size(final_node_zyx, 1) 
    vertices(final_node_zyx(i), :) = final_node_zyx(i, 
:); 
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end 
  
% plot 
figure; 
p=patch('faces',faces,'vertices',vertices(:, 2:end), 
'facecolor', 'flat', 'FaceVertexCData', dens, 
'edgecolor', 'none','facealpha', 1); 
view([0 1 0]); axis off; colormap(flipud(gray)) 
 
Code for smoothing intermediate densities in 
unwrapped stent topology results 
 
 
% reading image 
a = 
double(rgb2gray(imread('flash_traced_30_calci.png')))/255
; 
  
figure;imshow(a) 
  
% smooth 
f = fspecial('average', 3); 
smoothed = imfilter(a,f,'replicate'); 
figure;imshow(smoothed) 
  
  
% threshold 
isoval = 0.15; 
b = 1-smoothed; 
b(b>isoval) = 1; 
b(b<=isoval) = 0; 
figure;imshow(~b) 
  
 
Code for wrapping the smoothed optimised stent 
topologies 
 
 
%% analysing image 
z_max = 15; 
R = 2.475; 
x_temp = ~logical(rgb2gray(imread([file_path 
'final_30_calci.png']))); 
img = x_temp; 
nely = size(img,1);    nelx = size(img,2);    
  
connectivity=zeros(nelx*nely,4); 
for ii=1:nelx*nely 
    rw=mod(ii,nely); 
    cl=fix((ii-1)/nely)+1; 
    connectivity(ii,1)=cl-1+ii; 
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    connectivity(ii,2)=connectivity(ii,1)+1; 
    connectivity(ii,3)=connectivity(ii,1)+nely+1+1; 
    connectivity(ii,4)=connectivity(ii,3)-1; 
end 
  
prop_id_max = max(img(:)); 
prop = double(img(:)); 
prop(img==0) = prop_id_max+1; 
  
mat = [[1:nelx*nely]' prop connectivity]; 
fid5 = fopen([file_path 'elem_ori.txt'], 'w'); 
fprintf(fid5,'CQUAD4,%d,%d,%d,%d,%d,%d\n',mat.'); 
fclose(fid5); 
  
%% Processing  - Elements 
fid2 = fopen([file_path 'elem_ori.txt']); 
elem = textscan(fid2, '%s %d %d %d %d %d %d', 
'delimiter', ','); 
fclose(fid2); 
  
length_elem_list = size(elem{1},1); 
no_elem_in_cyl_cut = nely; 
  
no_nodes_in_cyl_cut = no_elem_in_cyl_cut+1; 
  
for(i=no_elem_in_cyl_cut:no_elem_in_cyl_cut:length_elem_l
ist) 
    elem{4}(i) = elem{4}(i); 
    elem{5}(i) = elem{5}(i)- no_elem_in_cyl_cut; 
    elem{6}(i) = elem{6}(i)- no_elem_in_cyl_cut; 
    elem{7}(i) = elem{7}(i); 
end 
  
  
fid4 = fopen([file_path 'elem.txt'], 'w'); 
mat = [elem{2}'; elem{3}'; elem{4}'; elem{5}'; elem{6}'; 
elem{7}']; 
fprintf(fid4,'CQUAD4,%d,%d,%d,%d,%d,%d\n',mat); 
fclose(fid4); 
  
%% Nodes 
theta = 2*pi/no_elem_in_cyl_cut*[0:no_elem_in_cyl_cut-1]; 
x = R*cos(theta)'; 
y = R*sin(theta)'; 
times = (length_elem_list/no_elem_in_cyl_cut); 
  
z = [0:z_max/times:z_max]'; 
  
nodes = zeros(no_nodes_in_cyl_cut*(length(z)),4); 
for(j = 1:length(z)) 
    k = (j-1)*no_nodes_in_cyl_cut; 
    nodes(k+1:k+no_nodes_in_cyl_cut,1) = 
[k+1:k+no_nodes_in_cyl_cut]; 
    nodes(k+1:k+no_nodes_in_cyl_cut-1,2) = x; 
    nodes(k+1:k+no_nodes_in_cyl_cut-1,3) = y; 
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    nodes(k+1:k+no_nodes_in_cyl_cut-1,4) = z(j); 
end 
  
fid3 = fopen([file_path 'node.txt'], 'w'); 
fprintf(fid3,'GRID,%d,,%f,%f,%f\n',nodes.'); 
fclose(fid3); 
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Nastran input deck for compliance minimisation 
 
The following input deck represents the optimisation model and 
parameters for stent optimisation based on 30% calcified artery plaque, 
to be analysed by Nastran. Other set of input decks are similar except 
the radial varying loading. 
$ Design Sensitivity and Optimization Analysis 
SOL 200 $ Specifies Design Sensitivity and Optimization Analysis solution 
sequence 
TIME 600 
CEND $ Designates the end of the Executive Control section 
$ Direct Text Input for Global Case Control Data 
ECHO = NONE $ Neither sorted nor unsorted Bulk Data will be printed 
MAXLINES = 999999999 $ Sets the maximum number of output lines 
DESOBJ = 1 $ Selects the DRESP entry to be used as the design objective.  
DESGLB = 1$ Selects the design constraints to be applied. 
 
ANALYSIS = STATICS 
SUBCASE 1 
$ Subcase name : Default 
   SUBTITLE=Default 
   SPC = 2 $ Selects a single point constraint set (DOF BCs) to be applied. 
   LOAD = 2 $ Selects a load to be applied. 
   DISPLACEMENT(SORT1,REAL)=ALL $ Specifies the form and type of 
displacement vector output. 
   SPCFORCES(SORT1,REAL)=ALL$ Specifies the SPC forces output. 
   STRESS(SORT1,REAL,VONMISES,BILIN)=ALL$ Specifies stress output. 
BEGIN BULK $ Designates the end of the Case Control Section and/or the 
beginning of a Bulk Data Section. 
$ Direct Text Input for Bulk Data 
PARAM,AUTOMSET,YES 
PARAM    POST    -1 $ Specifies the output form. 
PARAM   PRTMAXIM YES $ Specifies the output of maximums of applied 
loads, single-point forces of constraint, multi-point forces of constraint, and 
displacements. 
$ Elements and Element Properties for region: stent 
$ Defines the membrane, bending, transverse shear, and coupling properties 
of thin shell elements. The real value in the entry is 
the shell thickness. 
PSHELL   1       1      .2       1               1 
$ Pset: "stent" will be imported as: "pshell.1" 
$ Defines a curved quadrilateral shell or plane strain element with 4 grid 
points. 
CQUAD4   1       1       1       2       87      86 
CQUAD4   2       1       2       3       88      87 
$...etc. for all the elements 
$ Referenced Material Records 
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$ Material Record : PLA 
$ Description of Material : PLA 
MAT1     1      3500.           .36 1.3-9 
$ Multipoint Constraints of the Entire Model 
$ ID conflict : the PATRAN MPC ID was 1 
$Describes the connectivity of RBE3 elements to nodes on both ends of stent 
for free expansion and compression 
RBE3     6805            6970    123456 1.       123     1       2 
         3       4       5       6       7       8       9       10 
         11      12      13      14      15      16      17      18 
         19      20      21      22      23      24      25      26 
         27      28      29      30      31      32      33      34 
         35      36      37      38      39      40      41      42 
         43      44      45      46      47      48      49      50 
         51      52      53      54      55      56      57      58 
         59      60      61      62      63      64      65      66 
         67      68      69      70      71      72      73      74 
         75      76      77      78      79      80      81      82 
         83      84 
         UM      22      23      78      23      50      23 
$ Nodes of the Entire Model 
$ Defines the location of a geometric grid point (node), the directions of its 
displacement, and its permanent single-point 
constraints of the entire model. 
GRID*    1                              2.5             2.47499990463257 
*        0. 
GRID*    2                              2.5             2.46808052062988 
*       .18494039773941 
$...etc. for all the grid points 
$ Loads for Load Case : Default 
SPCADD   2       1 
LOAD     2      1.      1.       1 
$ Displacement Constraints of Load Set : fix_x_y 
$ Defines a set of single-point constraints (DOF BCs) 
SPC1     1       123456  6970 
$ Nodal Forces of Load Set : force 
$ Defines a static concentrated force at a grid point by specifying a vector. 
FORCE    1       1       1      0.00799      -1.      0.      0. 
FORCE    1       2       1      0.01158      -1.      0.      0. 
$...etc. for all the nodal force 
 
$ Optimisation Parameters : 
$ ...OPTIMISATION CONTROL 
$ Overrides default values of parameters using in design optimisation 
$Tcheck for avoiding checkerboard pattern. 
DOPTPRM  DESMAX  250     CONV1  1.-4 TCHECK 1 
$ Design Variables for TOPOLOGY Optimisation : 
$ Topology variable and symmetry manufacturing constraints. 
TOPVAR   1       PSHELL  PSHELL .4      .001    .2      3.       1 
         SYM     2      XY      ZX 
  
 
$         TDMIN  .1 
$ Global Target Constraints : MASS FRACTION 
DCONSTR  1       10001          0.3000 
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DRESP1   10001   FRM     FRMASS 
$ Objective Responses : Minimize Compliance 
DRESP1   1       COMPL   COMP 
$ Referenced Coordinate Frames 
CORD2C   1              10.      0.      0.     20.      0.      0. 
        10.      0.     10. 
CORD2R   2              10.      0.      0.     20.      0.      0. 
        10.      0.     10. 
ENDDATA ded0dc75 $ Designates the end of the Bulk Data Section 
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Appendix C 
 
Code for image analysis 
 
%reading first image 
image1=imread('1a.png'); 
figure;imshow(image1); 
%convert image1 to grey scale 
image2=rgb2gray(image1); 
figure;imshow(image2) 
%egde detection 
BW = edge(image2,'sobel',5e-2); 
figure;imshow(BW); 
figure;imshow(image2); 
imshow(BW); 
BW(BW==0)=nan; 
%reading second image 
image3=imread('1b.png'); 
%convert image3 to grey scale 
image4=rgb2gray(image3); 
figure;imshow(image4) 
%egde detection of image 4 
BW2 = edge(image4,'sobel',5e-2); 
figure;imshow(BW2); 
  
figure;imshow(image4); 
imshow(BW2); 
 
 
197 
 
BW2(BW2==0)=nan; 
  
%imfuse two images and place reference markers 
 C=imfuse(BW,BW2,'blend','Scaling','joint'); 
imwrite(C,'fused_image.png'); 
imshow(C) 
figure(99);imshow(C); 
x_center_line=[640;640]; 
y_center_line=[0;1280]; 
hold on; plot(x_center_line,y_center_line,'--y'); 
x_limleft=transpose(640:72:1000); 
x_limright=transpose(640:-72:280); 
 
y_limup=transpose(1280*ones(1,6)); 
y_limdown=transpose(0*ones(1,6)); 
up_left=[x_limleft,y_limup]; 
down_left=[x_limleft,y_limdown]; 
hold on;plot(down_left,up_left,'--c'); 
xb_limleft=transpose(210:72:640); 
for i=2:6 
    hold 
on;plot([x_limleft(i);x_limleft(i)],[y_limdown(i);y_limup
(i)],'--c'); 
end 
for i=2:6 
    hold 
on;plot([xb_limleft(i);xb_limleft(i)],[y_limdown(i);y_lim
up(i)],'--c'); 
end 
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Appendix D 
Mesh refinement and minimum 
member size (MMS) study of the 
preliminary load case scenarios 
The following figures present topology optimisation results of higher 
mesh densities and the variation due to the minimum member size 
control (MMS) option in Nastran topology optimisation of cylinder under 
different initial loading scenarios. 
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Figure 7-1: Mesh 2 (13685 elements) with uniform loading: (a) element density distribution, ρ, 
representing material densities between 0-1 (b) threshold 0.3 for element filtering and (c) FEM 
smoothing of the filtered elements. 
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Figure 7-2: Mesh 2 (13685 elements) with central crush loading: (a) element density distribution, ρ, 
representing material densities between 0-1 (b) threshold 0.3 for element filtering and (c) FEM 
smoothing of the filtered elements. 
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Figure 7-3: Mesh 2 (13685 elements) with torsional loading: (a) element density distribution, ρ, 
representing material densities between 0-1 (b) threshold 0.3 for element filtering and (c) FEM 
smoothing of the filtered elements. 
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Figure 7-4: Mesh 3 (47507 elements) with uniform loading and MMS 0.3: (a) element density 
distribution, ρ, representing material densities between 0-1 (b) threshold 0.25 for element filtering 
and (c) FEM smoothing of the filtered elements. 
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Figure 7-5: Mesh 3 (47507 elements) with uniform loading and MMS 0.4: (a) element density 
distribution, ρ, representing material densities between 0-1 (b) threshold 0.25 for element filtering 
and (c) FEM smoothing of the filtered elements. 
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Figure 7-6: Mesh 3 (47507 elements) with uniform loading and MMS 0.5: (a) element density 
distribution, ρ, representing material densities between 0-1 (b) threshold 0.25 for element filtering 
and (c) FEM smoothing of the filtered elements. 
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Figure 7-7: Mesh 3 (47507 elements) with central crush loading and MMS 0.3: (a) element density 
distribution, ρ, representing material densities between 0-1 (b) threshold 0.25 for element filtering 
and (c) FEM smoothing of the filtered elements. 
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Figure 7-8: Mesh 3 (47507 elements) with central crush loading and MMS 0.4: (a) element density 
distribution, ρ, representing material densities between 0-1 (b) threshold 0.25 for element filtering 
and (c) FEM smoothing of the filtered elements. 
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Figure 7-9: Mesh 3 (47507 elements) with central crush loading and MMS 0.5: (a) element density 
distribution, ρ, representing material densities between 0-1 (b) threshold 0.25 for element filtering 
and (c) FEM smoothing of the filtered elements. 
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Figure 7-10: Mesh 3 (47507 elements) with torsional loading and MMS 0.3: (a) element density 
distribution, ρ, representing material densities between 0-1 (b) threshold 0.25 for element filtering 
and (c) FEM smoothing of the filtered elements. 
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Figure 7-11: Mesh 3 (47507 elements) with torsional loading and MMS 0.4: (a) element density 
distribution, ρ, representing material densities between 0-1 (b) threshold 0.25 for element filtering 
and (c) FEM smoothing of the filtered elements. 
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Figure 7-12: Mesh 3 (47507 elements) with torsional loading and MMS 0.5: (a) element density 
distribution, ρ, representing material densities between 0-1 (b) threshold 0.25 for element filtering 
and (c) FEM smoothing of the filtered elements. 
 
